Photothermal spectroscopy-tomography devices, systems, and methods and spectroscopic imaging devices, systems, and methods
By integrating optical coherence tomography with photothermal spectroscopy, the system achieves rapid and accurate label-free imaging with subcellular resolution, addressing the limitations of bulky benchtop systems and enabling portable, point-of-care applications.
Patent Information
- Application Number
- PCT/US2026/027254
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-23
- Filing Date
- 2026-05-08
- Publication Date
- 2026-11-12
AI Technical Summary
Current microscopy approaches lack the ability to provide rapid and accurate label-free chemical and structural information, and existing photothermal mid-infrared spectroscopic imaging systems are bulky and limited to large benchtop setups.
The integration of optical coherence tomography (OCT) with photothermal spectroscopy, utilizing a pump and probe light source to induce and detect a photothermal response, enabling simultaneous structural and biochemical imaging with subcellular resolution, and the development of compact, portable devices for label-free imaging.
Provides high-resolution structural and biochemical imaging with subcellular resolution, enabling rapid and accurate label-free characterization of biological and inorganic samples, suitable for point-of-care and clinical applications.
Smart Images

Figure US2026027254_12112026_PF_FP_ABST
Abstract
Description
[0001] PHOTOTHERMAL SPECTROSCOPY-TOMOGRAPHY DEVICES, SYSTEMS, AND METHODS AND SPECTROSCOPIC IMAGING DEVICES, SYSTEMS, AND METHODS
[0002] CROSS-REFERENCE TO RELATED APPLICATIONS
[0003] This application claims the benefit of priority to U.S. Provisional Application No.
[0004] 63 / 802,812 filed May 9, 2025, and U.S. Provisional Application No. 63 / 810,907 filed May 23, 2025, each of which is hereby incorporated herein by reference in its entirety.
[0005] BACKGROUND
[0006] Current microscopy approaches lack the ability to provide rapid and accurate label-free chemical and structural information.
[0007] Photothermal mid-infrared spectroscopic imaging (MIRSI) is an emerging, label-free technology that can identify the molecular composition and structure of heterogeneous samples, such as tissue and polymers, on a microscopic scale. However, existing systems are bulky and limited to large benchtop setups.
[0008] Improved devices, systems, and methods are therefore needed. The devices, systems, and methods disclosed herein address these and other needs.
[0009] SUMMARY
[0010] In accordance with the purposes of the disclosed devices, methods, and systems as embodied and broadly described herein, the disclosed subject matter relates to photothermal spectroscopy-tomography devices, systems, and methods.
[0011] For example, disclosed herein are imaging methods, the methods comprising simultaneously subjecting a sample to optical coherence tomography and photothermal spectroscopy.
[0012] In some examples, the methods comprise: irradiating at least a portion of the sample at a location with a pump signal from a pump light source (e.g., a pump laser), thereby inducing a photothermal response in the sample; and subsequently detecting and analyzing a signal from a probe light source (e.g., a probe laser) via optical coherence tomography that also illuminates the sample; wherein the photothermal response induced by the pump signal is transferred to the probe signal, which is detected as a signal that is analyzed to thereby provide imaging of the sample.
[0013] In some examples, the methods comprise: irradiating at least a portion of the sample at a location with a pump signal from a pump laser, thereby inducing a photothermal response in the sample; and subsequently detecting and analyzing a signal from a probe laser via opticalcoherence tomography that also illuminates the sample; wherein the photothermal response induced by the pump signal is transferred to the probe signal, which is detected as a signal that is analyzed to thereby provide imaging of the sample.
[0014] In some examples, the method further comprises translocating the sample to thereby provide imaging of a plurality of locations of the sample.
[0015] In some examples, the pump light source has a wavelength of from 2000 nm to 25,000 nm. In some examples, the pump light source has a wavelength of from 5000 to 20000 nm, from 5000 to 12000 nm, or from 2000 to 12000 nm.
[0016] In some examples, the pump light source has a wavelength in the infrared region of the electromagnetic spectrum, such as the mid-infrared (MIR) region.
[0017] In some examples, the probe light source has a wavelength in the ultraviolet, visible, infrared, or other region of the electromagnetic spectrum. In some examples, the probe light source has a wavelength in the infrared region of the electromagnetic spectrum, such as the nearinfrared (NIR) region.
[0018] In some examples, the optical coherence tomography is leveraged to provide a common path interferometry for photothermal microscopy.
[0019] In some examples, the sample comprises a biological sample. In some examples, the sample comprises tissue. In some examples, the sample comprises ovarian tissue, endometrial tissue, cervical tissue, kidney tissue (e.g., kidney tissue features such as tubules and glomeruli),, bone marrow tissue, brain tissue (e.g., neuronal bundles in the brain), or a combination thereof. In some examples, the sample comprises collagen. In some examples, the sample comprises living cells, and the method is performed in situ on living cells.
[0020] In some examples, the sample comprises inorganic compounds.
[0021] In some examples, the sample comprises a polymer. In some examples, the sample comprises polystyrene, poly(methyl methacrylate) (PMMA), or a combination thereof.
[0022] In some examples, the sample comprises battery materials, solar panel materials, materials used in energy research, organic materials, unknown chemicals of interest, composite materials, materials used in art, historical artifacts and / or documents, diagnostically relevant constituents, heterogeneous structures, liquids, gases, oils, or a combination thereof.
[0023] In some examples, the method comprises photothermal mid-infrared spectroscopy coupled to optical coherence tomography, such as Fourier-domain optical coherence tomography.
[0024] In some examples, the method combines the high-resolution structural imaging of optical coherence tomography (OCT) with the biochemical contrast of mid-infrared photothermaldetection.
[0025] In some examples, the method is label-free.
[0026] In some examples, the method is substantially free of any added contrast agents.
[0027] In some examples, the method has subcellular resolution.
[0028] In some examples, the method has subcellular resolution and label-free specificity.
[0029] In some examples, the method further comprises use of machine-learning algorithms to further analyze the images.
[0030] In some examples, three-dimensional (3D) data are obtained. In some examples, two-dimensional (2D) mid-infrared data and three-dimensional OCT data are obtained simultaneously. In some examples, the mid-infrared and OCT data are combined into one dataset. In some examples, 3D data from OCT is used to complement 2D data from the midinfrared. In some examples, 2D chemical information from mid-infrared spectroscopy complements the morphological information from OCT. In some examples, the 3D imaging from OCT complements the chemical maps from the mid-infrared.
[0031] In some examples, the combination of the two methods provides more information than each method alone.
[0032] Also disclosed herein are devices for performing any of the methods disclosed herein. Also disclosed herein are photothermal spectroscopy-tomography devices comprising: a photothermal spectrometer integrated with an optical coherence topographer; wherein the device is configured to: irradiate at least a portion of a sample at a location with a pump signal from a pump light source (e.g., a pump laser), thereby inducing a photothermal response in the sample; and subsequently detect and analyze a probe signal from a probe light source (e.g., a probe laser) via optical coherence tomography that simultaneously illuminates the sample; wherein the photothermal response induced by the pump signal is transferred to the probe signal, which is detected as a signal that is analyzed to thereby provide imaging of the sample. In some examples, the device is configured to perform any of the methods disclosed herein.
[0033] In some examples, the device comprises: a pump light source (e.g., a pump laser); a probe light source (e.g., a probe laser); an optical component; and a detector; the pump light source being configured to provide a pump signal; the probe light source being configured to provide a probe signal; the optical component being configured to receive the pump signal and probe signal and focus each onto a sample, and subsequently transmit a measured signal to the detector.
[0034] In some examples, the device further comprises an optical fiber, a dichroic beam combiner, a light-routing component, a collimation optic, or a combination thereof.In some examples, the device further comprises an optical fiber, a single mode fiber, a dichroic beam combiner, a beam splitter, a beam circulator, a multi-mode fiber, a mirror such as an off-axis parabolic mirror, a collimator, an objective, or a combination thereof.
[0035] In some examples, the device comprises: a pump light source (e.g., a pump laser); a probe light source (e.g., a probe laser); a single mode fiber circulator; a dichroic beam combiner; an off-axis parabolic mirror; and a detector; the pump light source being configured to provide a pump signal; the off-axis parabolic mirror being configured to receive the pump signal and focus the pump signal onto the sample; the probe light source being configured to provide a probe signal; the single mode fiber circulator being configured to receive the probe signal from the probe light source and transmit the probe signal to the dichroic beam combiner; the dichroic beam combiner being configured to receive the probe signal from the single mode fiber circulator, and transmit the probe signal to the sample; and the dichroic beam combiner being further configured to subsequently receive and transmit a measured signal to the detector.
[0036] In some examples, the device further comprises one or more focusing elements (e.g., collimator, objective, lens, mirror, etc.).
[0037] In some examples, the device further comprises one or more additional components, such as a beam splitter, a beam circulator, a multi-mode fiber, or a combination thereof.
[0038] In some examples, the device further comprises a movable stage, the sample being supported by the movable stage. In some examples, the device further comprises a means for translocating the movable stage, thereby translocating the sample to thereby provide hyperspectral imaging of a plurality of locations of the sample.
[0039] In some examples, the pump light source has a wavelength of from 2000 nm to 25,000 nm. In some examples, the pump light source has a wavelength of from 5000 to 20000 nm, from 5000 to 12000 nm, or from 2000 to 12000 nm. In some examples, the pump light source has a wavelength in the infrared region of the electromagnetic spectrum, such as the mid-infrared (MIR) region.
[0040] In some examples, the pump light source comprises a laser, a light emitting diode (LED), or a combination thereof. In some examples, the pump light source comprises a laser. In some examples, the pump light source comprises a QCL (e.g., a pulsed QCL), a supercontinuum laser, an OPO laser, a femtosecond laser, a picosecond laser, a comb laser, or a combination thereof.
[0041] In some examples, the device further comprises a modulator coupled to the pump light source, the waveform generator configured to modulate the pump signal. In some examples, the modulator comprises a waveform generator.
[0042] In some examples, the probe light source comprises a laser, a black body source, a lightemitting diode (LED), a continuous wave (CW) light source, a pulsed light source, or a combination thereof. In some examples, the probe light source comprises a laser, such as a swept source laser and / or a broadband laser.
[0043] In some examples, the probe light source has a wavelength in the ultraviolet, visible, infrared, or other region of the electromagnetic spectrum. In some examples, the probe light source has a wavelength in the infrared region of the electromagnetic spectrum, such as the nearinfrared (NIR) region.
[0044] In some examples, the device further comprises an optical fiber, for example that is configured to transmit light. In some examples, the optical fiber comprises a single mode fiber, a chalcogenide fiber, a multi-mode fiber, a hollow core fiber, a photonic crystal fiber, a flexible fiber optic, or a combination thereof.
[0045] In some examples, the device further comprises a light-routing component, for example that is used to direct light to the detector. In some examples, the light-routing component comprises an optical coupler, a fiber coupler, a free-space coupler, or a combination thereof. In some examples, the light-routing component is replaced by a circulator, a beam splitter, a beam combiner, or a combination thereof.
[0046] In some examples, the device further comprises a condenser configured to couple the pump signal into the optical fiber. In some examples, the condenser is configured to receive the pump signal from the pump light source and mode match the pump signal with the optical fiber before the pump signal enters the optical fiber. In some examples, the condenser is an aspheric condenser, a reflective mirror, a lens (e.g., a set of lenses), an objective (e.g., a Cassegrain objective), or a combination thereof. In some examples, the condenser is an aspheric condenser.
[0047] In some examples, the device further comprises a fixed focus collimator configured to receive the probe signal from the light-routing component, focus the probe signal, and transmit the focused probe signal to the dichroic beam combiner.
[0048] In some examples, the device further comprises a variable focus collimator configured to receive the probe signal grom the fiber coupler, focus the probe signal, and transmit the focused probe signal to the dichroic beam combiner.
[0049] In some examples, the dichroic beam combiner comprises a short-pass dichroic beam combiner and / or a long-pass dichroic beam combiner. In some examples, the dichroic beam combiner comprises a short-pass dichroic beam combiner. In some examples, the dichroic beam combiner is further configured to align the pump signal from the optical fiber and the probe signal from the light-routing component.
[0050] In some examples, the device further comprises a focusing optic, which can, for example,be used to focus the pump beam and / or the probe beam. In some examples, the focusing optic comprises a mirror, such as a curved mirror. In some examples, the focusing optic comprises an off-axis parabolic mirror.
[0051] In some examples, the device further comprises a movable stage, the focusing optic being mounted on the movable stage. In some examples, the movable stage comprises a set of cascaded rotational-translation stages. In some examples, the device further comprises a means for translating the movable stage, thereby translocating the focusing optic to thereby provide imaging of a plurality of locations of the sample.
[0052] In some examples, the device further comprises a means for translating the pump light source and / or probe light source, for example laterally, to thereby provide imaging of a plurality of locations of the sample.
[0053] In some examples, the detector comprises a photodiode (e.g., an array of photodiodes), a detection element (e.g., an array of detection elements), a camera system, or a combination thereof. In some examples, the detector comprises a photodiode.
[0054] In some examples, the device further comprises a computing device operably coupled to one or more device components.
[0055] In some examples, the sample comprises tissue. In some examples, the sample comprises ovarian tissue, endometrial tissue, cervical tissue, kidney tissue (e.g., kidney tissue features such as tubules and glomeruli),, bone marrow tissue, brain tissue (e.g., neuronal bundles in the brain), or a combination thereof. In some examples, the sample comprises collagen.
[0056] In some examples, the device enables in vivo label-free imaging of biological tissue. In some examples, the device is configured to be coupled to an endoscope to provide in situ imaging of biological tissue.
[0057] In some examples, the device enables label free characterization of inorganic and organic material.
[0058] In some examples, the device is diagnostically useful.
[0059] In some examples, the device provides structural and chemical information.
[0060] In some examples, the device provides molecular information relevant for disease analysis.
[0061] In some examples, the sample comprises inorganic compounds.
[0062] In some examples, the sample comprises a polymer. In some examples, the sample comprises polystyrene, poly(methyl methacrylate) (PMMA), or a combination thereof.
[0063] In some examples, the sample comprises battery materials, solar panel materials, materials used in energy research, organic materials, unknown chemicals of interest, compositematerials, materials used in art, historical artifacts and / or documents, diagnostically relevant constituents, heterogeneous structures, liquids, gases, oils, or a combination thereof.
[0064] In some examples, the device being as shown in Figure 4.
[0065] In some examples, the device couples photothermal mid-infrared spectroscopy to optical coherence tomography, such as Fourier-domain optical coherence tomography.
[0066] In some examples, the device combines the high-resolution structural imaging of optical coherence tomography (OCT) with the biochemical contrast of mid-infrared photothermal detection.
[0067] In some examples, the device is configured such that optical coherence tomography is leveraged to provide a common path interferometry for photothermal microscopy.
[0068] In some examples, the device has subcellular resolution.
[0069] In some examples, the device is configured to be handheld.
[0070] In some examples, the device is portable.
[0071] In some examples, the device is a point-of-care device.
[0072] In some examples, the device provides 3D structural information.
[0073] In some examples, the device provides chemical information.
[0074] In some examples, the device provides simultaneous 3D and chemical information. In some examples, the device provides diagnostically relevant molecular information. In some examples, the device is flexible, easy to use, provides immediate feedback, provides diagnostic information, assists with real-time analysis, provides label-free contrast, or a combination thereof.
[0075] In some examples, the device can be in contact with a human in a safe manner.
[0076] In some examples, the device is miniaturized and compact.
[0077] Also disclosed herein are methods of use of any of the devices disclosed herein. In some examples, the method comprises using the device to perform any of the methods disclosed herein.
[0078] In some examples, the method comprises using the device in a clinical or field setting. In some examples, the method comprises using the device in a point-of-care setting. In some examples, the method comprises using the device in a biomedical setting or application.
[0079] In some examples, the method comprises using the device for biological research, clinical diagnostics, or a combination thereof.
[0080] In some examples, the method comprises using the device for diagnostic imaging of complex biological systems.In some examples, the method further comprises collecting the sample.
[0081] In some examples, the method comprises diagnosing and / or monitoring a condition or disease in a subject based on a property of the sample.
[0082] In some examples, the method comprises using the device in biomedical and / or clinical applications, for example for disease visualization and diagnosis.
[0083] In some examples, the method comprises using the device to provide rapid diagnosis at a point of care and / or clinical setting.
[0084] In some examples, the method is minimally invasive.
[0085] In some examples, the method further comprises selecting a course of therapy for the subject based on the property of the sample.
[0086] In some examples, the method comprises using the device for material characterization, using the device for field characterization of oil samples, using the device for energy research, using the device for battery characterization, using the device for solar panel characterization, using the device for field identification of hazardous materials, using the device for field identification of unknown chemicals, using the device for field identification of historical artifacts, or a combination thereof.
[0087] The disclosed subject matter also relates to spectroscopic imaging devices, systems, and methods.
[0088] For example, disclosed herein are spectroscopic imaging device comprising: a pump light source (e.g., laser); a probe light source (e.g., laser); an optical fiber (e.g., a single mode fiber); a light-routing component (e.g., a fiber coupler); a dichroic beam combiner; a collimation optic (e.g., a reflective collimator); a focusing optic (e.g., an off-axis parabolic mirror); and a detector.
[0089] The pump light source is configured to provide a pump signal. The optical fiber is configured to receive the pump signal from the pump light source and transmit the pump signal to a dichroic beam combiner. The probe light source is configured to provide a probe signal. The light-routing component is configured to receive the probe signal from the probe light source and transmit the probe signal to the dichroic beam combiner. The collimation optic is configured to receive the pump signal from the optical fiber and transmit the pump signal to the dichroic beam combiner. The dichroic beam combiner is configured to receive and combine the pump signal from the collimation optic and the probe signal from the light-routing component, and transmit the combined signal to the focusing optic. The focusing optic is configured to receive the combined signal and focus the combined signal onto a sample, and subsequently transmit a measured signal back through the dichroic beam combiner to the light-routing component and then to a detector.The device is configured to irradiate at least a portion of a sample at a location with a pump signal, thereby inducing a photothermal response in the sample; and subsequently detect and analyze a signal from a probe signal that simultaneously illuminates at least the portion of the sample; wherein the photothermal response induced by the pump signal is transferred to the probe signal, which is subsequently photodetected as a signal that is analyzed to thereby provide imaging of the sample.
[0090] In some examples, the device further comprises one or more focusing elements (e.g., collimator, objective, lens, mirror, etc.).
[0091] In some examples, the device further comprises a movable stage, the sample being supported by the movable stage. In some examples, the device further comprises a means for translocating the movable stage, thereby translocating the sample to thereby provide imaging of a plurality of locations of the sample.
[0092] In some examples, the pump light source has a wavelength of from 2000 to 25,000 nm. In some examples, the pump light source has a wavelength of from 5000 to 20000 nm, from 5000 to 12000 nm, or from 2000 to 12000 nm.
[0093] In some examples, the pump light source has a wavelength in the infrared region of the electromagnetic spectrum, such as the mid-infrared region.
[0094] In some examples, the pump light source comprises a laser, a black body source, a light emitting diode (LED), or a combination thereof.
[0095] In some examples, the pump light source comprises a laser. In some examples, the pump light source comprises a QCL (e.g., a pulsed QCL), a supercontinuum laser, an OPO laser, a femtosecond laser, a picosecond laser, a comb laser, or a combination thereof.
[0096] In some examples, the device further comprises a modulator coupled to the pump light source, the waveform generator configured to modulate the pump signal. In some examples, the modulator comprises a waveform generator.
[0097] In some examples, the probe light source comprises a laser, a black body source, a light emitting diode (LED), a continuous wave (CW) light source, a pulsed light source, or a combination thereof. In some examples, the probe light source comprises a laser.
[0098] In some examples, the probe light source has a wavelength in the ultraviolet, visible, infrared, or other region of the electromagnetic spectrum. In some examples, the probe light source has a wavelength in visible region (e.g., from 400 to 700 nm) of the electromagnetic spectrum.
[0099] In some examples, the optical fiber comprises a chalcogenide fiber. In some examples, the optical fiber comprises a single mode fiber (e.g., a mid-infrared (MIR) chalcogenide singlemode fiber), a multi-mode fiber, a hollow core fiber, a photonic crystal fiber, or a combination thereof. In some examples, the optical fiber is a flexible fiber optic.
[0100] In some examples, the light-routing component comprises an optical coupler, a fiber coupler, a free-space coupler, or a combination thereof.
[0101] In some examples, the light-routing component is replaced by a circulator, a beam splitter, a beam combiner, or a combination thereof.
[0102] In some examples, the device further comprises a condenser configured to couple the pump signal into the optical fiber. In some examples, the condenser is configured to receive the pump signal from the pump light source and mode match the pump signal with the optical fiber before the pump signal enters the optical fiber. In some examples, the condenser is an aspheric condenser, a reflective mirror, a lens (e.g., a set of lenses), an objective (e.g., a Cassegrain objective), or a combination thereof. In some examples, the condenser is an aspheric condenser.
[0103] In some examples, the device further comprises a fixed focus collimator configured to receive the probe signal from the light-routing component, focus the probe signal, and transmit the focused probe signal to the dichroic beam combiner.
[0104] In some examples, the device further comprises a variable focus collimator configured to receive the probe signal grom the fiber coupler, focus the probe signal, and transmit the focused probe signal to the dichroic beam combiner.
[0105] In some examples, the dichroic beam combiner comprises a short-pass dichroic beam combiner and / or a long-pass dichroic beam combiner. In some examples, the dichroic beam combiner comprises a short-pass dichroic beam combiner.
[0106] In some examples, the dichroic beam combiner is further configured to align the pump signal from the optical fiber and the probe signal from the light-routing component.
[0107] In some examples, the focusing optic comprises an off-axis parabolic mirror.
[0108] In some examples, the spectroscopic imaging device comprises: a pump laser; a probe laser; a single mode fiber; a fiber coupler; a dichroic beam combiner; a reflective collimator; an off-axis parabolic mirror; and a detector. The pump laser is configured to provide a pump signal. The single mode fiber is configured to receive the pump signal from the pump laser and transmit the pump signal to a dichroic beam combiner. The probe laser is configured to provide a probe signal. The fiber coupler is configured to receive the probe signal from the probe laser and transmit the probe signal to the dichroic beam combiner. The reflective collimator is configured to receive the pump signal from the single mode fiber and transmit the pump signal to the dichroic beam combiner. The dichroic beam combiner is configured to receive and combine the pump signal from the reflective collimator and the probe signal from the fiber coupler, andtransmit the combined signal to the off-axis parabolic mirror. The off-axis parabolic mirror is configured to receive the combined signal and focus the combined signal onto a sample, and subsequently transmit a measured signal back through the dichroic beam combiner to the fiber coupler and then to a detector. The device is configured to: irradiate at least a portion of a sample at a location with a pump signal, thereby inducing a photothermal response in the sample; and subsequently detect and analyze a signal from a probe signal that simultaneously illuminates at least the portion of the sample; wherein the photothermal response induced by the pump signal is transferred to the probe signal, which is subsequently photodetected as a signal that is analyzed to thereby provide imaging of the sample.
[0109] In some examples, the device further comprises a movable stage, the focusing optic being mounted on the movable stage. In some examples, the movable stage comprises a set of cascaded rotational-translation stages. In some examples, the device further comprises a means for translating the movable stage, thereby translocating the focusing optic to thereby provide imaging of a plurality of locations of the sample.
[0110] In some examples, the device further comprises a means for translating the pump light source and / or probe light source, for example laterally, to thereby provide imaging of a plurality of locations of the sample.
[0111] In some examples, the detector comprises a photodiode (e.g., an array of photodiodes), a detection element (e.g., an array of detection elements), a camera system, or a combination thereof. In some examples, the detector comprises a photodiode.
[0112] In some examples, the device further comprises a computing device operably coupled to one or more device components.
[0113] In some examples, the sample comprises a biological sample. In some examples, the sample comprises tissue. In some examples, the sample comprises ovarian tissue, endometrial tissue, cervical tissue, kidney tissue, bone marrow tissue, brain tissue, or a combination thereof.
[0114] In some examples, the sample comprises collagen.
[0115] In some examples, the device enables in vivo label-free imaging of biological tissue. In some examples, the device is configured to be coupled to an endoscope to provide in situ imaging of biological tissue.
[0116] In some examples, the sample comprises inorganic compounds.
[0117] In some examples, the device enables label-free characterization of inorganic and organic material.
[0118] In some examples, the sample comprises a polymer. In some examples, the sample comprises polystyrene, poly(methyl methacrylate) (PMMA), or a combination thereof.In some examples, the sample comprises battery materials, solar panel materials, materials used in energy research, organic materials, unknown chemicals of interest, composite materials, materials used in art, historical artifacts and / or documents, diagnostically relevant constituents, heterogeneous structures, liquids, gases, oils, or a combination thereof.
[0119] In some examples, the device being as shown in Figure 11.
[0120] In some examples, the device comprises a photothermal mid-infrared spectroscopic imaging device.
[0121] In some examples, the device is compact.
[0122] In some examples, the device is smaller than a traditional bench-top device.
[0123] In some examples, the device has a footprint that is 10 sq. ft or less in size, such as 4 sq. ft. or less or 2 sq. ft. or less in size.
[0124] In some examples, the device has subcellular resolution.
[0125] In some examples, the device has comparable or better performance than a state-of-the-art benchtop system.
[0126] In some examples, the device is configured to be handheld.
[0127] In some examples, the device is portable.
[0128] In some examples, the device is a point-of-care device.
[0129] In some examples, the device is flexible, easy to use, provides immediate feedback, provides diagnostic information, assists with real-time analysis, provides label-free contrast, or a combination thereof.
[0130] In some examples, the device can be in contact with a human in a safe manner.
[0131] Also disclosed herein are methods of use of any of the devices disclosed herein.
[0132] In some examples, the method comprises using the device in a clinical or field setting. In some examples, the method comprises using the device in a point-of-care setting. In some examples, the method comprises using the device in a hospital, clinical setting, field application in the plastics and materials industries, or a combination thereof.
[0133] In some examples, the method comprises using the device in a biomedical setting or application.
[0134] In some examples, the method further comprises collecting the sample.
[0135] In some examples, the method comprises diagnosing and / or monitoring a condition or disease in a subject based on a property of the sample.
[0136] In some examples, the method is non-invasive.
[0137] In some examples, the method further comprises selecting a course of therapy for the subject based on the property of the sample.In some examples, the method comprises using the device for material characterization, using the device for field characterization of oil samples, using the device for energy research, using the device for battery characterization, using the device for solar panel characterization, using the device for field identification of hazardous materials, using the device for field identification of unknown chemicals, using the device for field identification of historical artifacts, or a combination thereof.
[0138] Also disclosed herein are spectroscopic imaging methods, for example wherein the methods comprise using any of the devices disclosed herein.
[0139] In some examples, the methods comprise: irradiating at least a portion of the sample at a location with the pump signal from a pump light source, thereby inducing a photothermal response in the sample; and subsequently detecting and analyzing a probe signal from the probe light source that simultaneously illuminates the sample; wherein the photothermal response induced by the pump signal is transferred to the probe signal, which is subsequently photodetected as a signal that is analyzed to thereby provide imaging of the sample.
[0140] In some examples, the method further comprises translocating the sample and / or at least a portion of the device to thereby provide imaging of a plurality of locations of the sample.
[0141] In some examples, the method comprises photothermal mid-infrared spectroscopy.
[0142] In some examples, the method is label-free.
[0143] In some examples, the method is substantially free of any added contrast agents.
[0144] In some examples, the method has subcellular resolution.
[0145] Additional advantages of the disclosed devices, systems, and methods will be set forth in part in the description which follows, and in part will be obvious from the description. The advantages of the disclosed devices, systems, and methods will be realized and attained by means of the elements and combinations particularly pointed out in the appended claims. It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the disclosed systems and methods, as claimed.
[0146] The details of one or more embodiments of the invention are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the invention will be apparent from the description and drawings, and from the claims.
[0147] BRIEF DESCRIPTION OF THE FIGURES
[0148] The accompanying figures, which are incorporated in and constitute a part of this specification, illustrate several aspects of the disclosure, and together with the description, serveto explain the principles of the disclosure.
[0149] Figure 1. System Characterization using a custom PMMA USAF target and Arden Phantom. (A) Bright-field microscopy image of USAF target. (B) OCT en face scanning image. (C) OCT-MIP scanning image. (D) Commercial Photothermal spectroscopic system scanning image. (E) A 3D image of the OCT phantom acquired by system. (F) B scan and en face image of the OCT phantom. The m indicate the phantom group number used for calculating the lateral resolution. The smallest distinguished target is m = 2, line 10, with resolution 21 pm.
[0150] Background noise caused by common-path has been subtracted.
[0151] Figure 2. Figure A, B, and C show the microscopy image, OCT enface image and MIP image at 1660 cm’1for 25 pm Polystyrene (PS) beads. Figure E, F, and G show the same types of images for 45 pm PST beads. Figure G shows the PS spectrum obtained from the system described herein versus that from the commercial system.
[0152] Figure 3. Images of mouse kidney tissue. Column I shows images of Masson’s Trichrome stained tissue sections obtained by the inverted microscope. The collagen tissue stains as green and muscle stain as red under Masson’s Tri chrome stain. Column II are the OCT en face images of the corresponding adjacent sections. Column III and IV are the MIP images from the system described herein and commercial system respectively. The MIP images were obtained at 1240 cm’1which corresponds to the collagen absorption peak. Scale bars are 300 pm.
[0153] Figure 4. (A) 3D rendered model of the Mid-infrared photothermal (MIP) OCT spectroscopic imaging system. The near-infrared (NIR) swept-source laser, used as probe beam and red light source used for microscopy illumination are co-aligned at the short-pass dichroic and focused on the sample. The common-path interferometry fringes is collected and sent to photodiode through optical fiber circulator. The mid-infrared (MIR) pump light from the QCL are focused on the same spot of NIR using the off-axis parabolic mirror (OAP). The sample is placed on an XY translational stage. (B) The mechanism of MIP signal detection via commonpath interferometry OCT. A CaF2 window is placed on the top of the sample to create two reference light, reflected light from the top surface Et and bottom surface Eb. The MIR pulsed light was modulated electronically to create MIP heating and cooling cycles (hot and cold), resulting in the periodic change of the NIR scattered light Esand Es’ due to the thermal expansion and change of refractive index (RI). Repeated OCT raw signal / line scans (A-scan) are recorded over multiple MIP heating and cooling cycles for each sample position. (C) The diagram of extracting MIP signal from OCT raw signals. The optical surface of the reference plate proximal to the sample was used as the reference, marked as Eb. Each raw signal consists of superimposed interferogram: the interference between light reflection of top and bottomsurfaces of the reference plate, marked as Eb + Et, which is free from MIP modulation, and the interference between bottom surface and scattered light of sample in different MIP cycles, Eb+Es(cold) or Eb+Es’ (hot). The MIP response causes the phase shift (delta phi) of the interferometry. Through Fourier Transform (FT), the quantified phase shift are able to be calculated. By plotting the phase changes over the MIP cycles, the MIP information is extracted.
[0154] Figure 5. Schematic illustration of an example computing device.
[0155] Figure 6. Characterization results: Confocal scanning images of groups 4, 5 and groups 6, 7 are presented in Figures A and D, respectively. Corresponding MIRSI images obtained at 1240 cm’1from the system described herein are shown in Figures B and E. Figures C and F are images of the same sample from the benchtop MIRSI system at the same wavenumber. The images in Figures A and B were obtained with 5 pm sampling and those in Figures D and E have 1 pm sampling. Both C and F were obtained with 0.5 pm sampling.
[0156] Figure 7. Figures A, B, and C show the confocal scanning image for 5 pm PMMA beads and Figures D, E, and F are the corresponding MIRSI images at 1240 cm’1. Figure H plots the PMMA spectrum obtained from the system described herein vs. that from the benchtop system. The confocal and MIRSI images of 2 pm polystyrene (PST) beads are shown in Figures G and I respectively. The MIRSI image was obtained at 1319 cm’1. The line profile of the central bead is plotted in Figure J along with the fitted Gaussian curve to show the point-spread function of the imaging system. Finally, the image of a 5 pm PMMA bead obtained from the benchtop system is shown in Figure K. Scale bars are 5 pm.
[0157] Figure 8. Images of cervical and ovarian tissue are shown in this set of figures. Figures in rows A and B correspond to cervical tissue and those in rows C and D are ovarian tissue. Images of H&E stained tissue sections were obtained using an inverted microscope and shown in the figures of column I. The stromal tissue becomes violet under H&E stain and the epithelium becomes bright pink. Column II are the confocal scanning images of the corresponding adjacent sections. MIRSI images obtained from the system described herein are in the figures of column III. Column IV are the MIRSI images obtained from the benchtop system. The MIRSI images were obtained at 1240 cm’1which corresponds to the collagen absorption peak. Scale bars are 200 pm.
[0158] Figure 9. Figure D shows the bright field image of a human bone biopsy sample. Figure E shows the Masson’s tri chrome stained adjacent section of the sample. The MIRSI image at the collagen peak is shown in figure F. The MIRSI image was collected on the section shown in figure D. A region of interest was magnified and the results are shown in Figures A, B, and C. The region of interest encircled in yellow shows a blood vessel and the surrounding tissue.Masson’s tri chrome stains collagen fibers in blue which are seen to be prevalent around the blood vessel. High MIRSI signal coming from bone is indicated by the red arrow.
[0159] Figure 10. Results for rotational -translational scanning method. Figures A and B are confocal scanning and MIRSI image of USAF target respectively. The confocal scanning and MIRSI images of a mouse kidney section placed on a silicon window is shown in Figures C and D respectively. The yellow circles highlight a glomerulus in the kidney. Scale bars are 100 pm.
[0160] Figure 11. 3D rendered model of the miniaturized OPTIR microscope. Probe light from the red light source and pump light from the QCL are co-aligned at the short-pass dichroic and focused on the sample using the OAP. The OAP is mounted on a set of cascaded rotational-translational stages. This movement provides two-axis scanning of the beam. The sample is also mounted on an XY translational stage. In this manner, the sample can be scanned either by moving the beam or moving the sample.
[0161] DETAILED DESCRIPTION
[0162] The devices, methods, and systems described herein may be understood more readily by reference to the following detailed description of specific aspects of the disclosed subject matter and the Examples included therein.
[0163] Before the present devices, methods, and systems are disclosed and described, it is to be understood that the aspects described below are not limited to specific synthetic methods or specific reagents, as such may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular aspects only and is not intended to be limiting.
[0164] Also, throughout this specification, various publications are referenced. The disclosures of these publications in their entireties are hereby incorporated by reference into this application in order to more fully describe the state of the art to which the disclosed matter pertains. The references disclosed are also individually and specifically incorporated by reference herein for the material contained in them that is discussed in the sentence in which the reference is relied upon.
[0165] In this specification and in the claims that follow, reference will be made to a number of terms, which shall be defined to have the following meanings.
[0166] Throughout the description and claims of this specification the word “comprise” and other forms of the word, such as “comprising” and “comprises,” means including but not limited to, and is not intended to exclude, for example, other additives, components, integers, or steps. As used in the specification and in the claims, the term “comprising” can include the aspects “consisting of’ and “consisting essentially of.”As used in the description and the appended claims, the singular forms “a,” “an,” and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to “a composition” includes mixtures of two or more such compositions, reference to “an agent” includes mixtures of two or more such agents, reference to “the component” includes mixtures of two or more such components, and the like.
[0167] “Optional” or “optionally” means that the subsequently described event or circumstance can or cannot occur, and that the description includes instances where the event or circumstance occurs and instances where it does not.
[0168] Ranges can be expressed herein as from “about” one particular value, and / or to “about” another particular value. By “about” is meant within 5% of the value, e.g., within 4, 3, 2, or 1% of the value. When such a range is expressed, another aspect includes from the one particular value and / or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent “about,” it will be understood that the particular value forms another aspect. It will be further understood that the endpoints of each of the ranges are significant both in relation to the other endpoint, and independently of the other endpoint.
[0169] Values can be expressed herein as an “average” value. “Average” generally refers to the statistical mean value.
[0170] By “substantially” is meant within 5%, e.g., within 4%, 3%, 2%, or 1%.
[0171] “Exemplary” means “an example of’ and is not intended to convey an indication of a preferred or ideal embodiment. “Such as” is not used in a restrictive sense, but for explanatory purposes.
[0172] It is understood that throughout this specification the identifiers “first” and “second” are used solely to aid in distinguishing the various components and steps of the disclosed subject matter. The identifiers “first” and “second” are not intended to imply any particular order, amount, preference, or importance to the components or steps modified by these terms.
[0173] References in the specification and concluding claims to parts by weight of a particular element or component in a composition denotes the weight relationship between the element or component and any other elements or components in the composition or article for which a part by weight is expressed. Thus, in a compound containing 2 parts by weight of component X and 5 parts by weight component Y, X and Y are present at a weight ratio of 2:5, and are present in such ratio regardless of whether additional components are contained in the compound.
[0174] A weight percent (wt. %) of a component, unless specifically stated to the contrary, is based on the total weight of the formulation or composition in which the component is included.
[0175] The term “or combinations thereof’ as used herein refers to all permutations andcombinations of the listed items preceding the term. For example, “A, B, C, or combinations thereof’ is intended to include at least one of: A, B, C, AB, AC, BC, or ABC, and if order is important in a particular context, also BA, CA, CB, CBA, BCA, ACB, BAC, or CAB.
[0176] Continuing with this example, expressly included are combinations that contain repeats of one or more item or term, such as BB, AAA, AB, BBC, AAABCCCC, CBBAAA, CAB ABB, and so forth. The skilled artisan will understand that typically there is no limit on the number of items or terms in any combination, unless otherwise apparent from the context.
[0177] As used herein the term “plurality” means 2 or more (e.g., 3 or more; 4 or more; 5 or more; 10 or more; 15 or more; 20 or more; 25 or more; 30 or more; 40 or more; 50 or more; 75 or more; 100 or more; 150 or more; 200 or more; 250 or more; 300 or more; 400 or more; 500 or more; 750 or more; 1000 or more; 1500 or more; 2000 or more; 2500 or more; 3000 or more; 4000 or more; or 5000 or more).
[0178] The term “artificial intelligence” is defined herein to include any technique that enables one or more computing devices or comping systems (i.e., a machine) to mimic human intelligence. Artificial intelligence (Al) includes, but is not limited to, knowledge bases, back-propagation bases, machine learning, representation learning, and deep learning.
[0179] The term “machine learning” is defined herein to be a subset of Al that enables a machine to acquire knowledge by extracting patterns from raw data. Machine learning techniques include, but are not limited to, logistic regression, support vector machines (SVMs), decision trees, Naive Bayes classifiers, and artificial neural networks. The term “representation learning” is defined herein to be a subset of machine learning that enables a machine to automatically discover representations needed for feature detection, prediction, or classification from raw data. Representation learning techniques include, but are not limited to, autoencoders. The term “deep learning” is defined herein to be a subset of machine learning that that enables a machine to automatically discover representations needed for feature detection, prediction, classification, etc. using layers of processing. Deep learning techniques include, but are not limited to, artificial neural network or multilayer perceptron (MLP).
[0180] Machine learning models include supervised, semi-supervised, and unsupervised learning models. In a supervised learning model, the model learns a function that maps an input (also known as feature or features) to an output (also known as target or target) during training with a labeled data set (or dataset). In an unsupervised learning model, the model learns a function that maps an input (also known as feature or features) to an output (also known as target or target) during training with an unlabeled data set. In a semi-supervised model, the model learns a function that maps an input (also known as feature or features) to an output (also known as targetor target) during training with both labeled and unlabeled data.
[0181] Photothermal-Tomography Spectroscopy Devices, Systems, and Methods Described herein are photothermal-tomography spectroscopy devices, systems, and methods.
[0182] For example, described herein is an imaging method, the method comprising simultaneously subjecting a sample to optical coherence tomography and photothermal spectroscopy.
[0183] In some examples, the method comprises: irradiating at least a portion of the sample at a location with a pump signal from a pump light source (e.g., a pump laser), thereby inducing a photothermal response in the sample; and subsequently detecting and analyzing a signal from a probe light source (e.g., a probe laser) via optical coherence tomography that also illuminates the sample; wherein the photothermal response induced by the pump signal is transferred to the probe signal, which is detected as a signal that is analyzed to thereby provide imaging of the sample.
[0184] In some examples, the method further comprises translocating the sample to thereby provide imaging of a plurality of locations of the sample.
[0185] In some examples, the optical coherence tomography is leveraged to provide a common path interferometry for photothermal microscopy.
[0186] In some examples, the method comprises photothermal mid-infrared spectroscopy coupled to optical coherence tomography, such as Fourier-domain optical coherence tomography.
[0187] In some examples, the method combines the high-resolution structural imaging of optical coherence tomography (OCT) with the biochemical contrast of mid-infrared photothermal detection.
[0188] In some examples, the method is label-free.
[0189] In some examples, the method is substantially free of any added contrast agents.
[0190] In some examples, the method has subcellular resolution.
[0191] In some examples, the method has subcellular resolution and label-free specificity.
[0192] In some examples, the method further comprises use of machine-learning algorithms to further analyze the images.
[0193] In some examples, three-dimensional (3D) data are obtained from the system. In some examples, two-dimensional (2D) mid-infrared data and three-dimensional OCT data are obtained simultaneously. In some examples, the mid-infrared and OCT data are combined into one dataset. In some examples, 3D data from OCT is used to complement 2D data from the mid-infrared. In some examples, 2D chemical information from mid-infrared spectroscopy complements the morphological information from OCT. In some examples, the 3D imaging from OCT complements the chemical maps from the mid-infrared. In some examples, the combination of the two methods provides more information than each method alone.
[0194] Also disclosed herein are devices, for example devices for performing any of the methods described herein.
[0195] For example, also disclosed herein are photothermal spectroscopy-tomography devices comprising: a photothermal spectrometer integrated with an optical coherence topographer; wherein the device is configured to: irradiate at least a portion of a sample at a location with a pump signal from a pump light source (e.g., a pump laser), thereby inducing a photothermal response in the sample; and subsequently detect and analyze a probe signal from a probe light source (e.g., a probe laser) via optical coherence tomography that simultaneously illuminates the sample; wherein the photothermal response induced by the pump signal is transferred to the probe signal, which is detected as a signal that is analyzed to thereby provide imaging of the sample.
[0196] In some examples, the device comprises: a pump light source (e.g., a pump laser); a probe light source (e.g., a probe laser); an optical component; and a detector; the pump light source being configured to provide a pump signal; the probe light source being configured to provide a probe signal; the optical component being configured to receive the pump signal and probe signal and focus each onto a sample, and subsequently transmit a measured signal to the detector.
[0197] In some examples, the device further comprises an optical fiber, a dichroic beam combiner, a light-routing component, a collimation optic, or a combination thereof.
[0198] In some examples, the device further comprises an optical fiber, a single mode fiber, a dichroic beam combiner, a beam splitter, a beam circulator, a multi-mode fiber, a mirror such as an off-axis parabolic mirror, a collimator, an objective, or a combination thereof.
[0199] In some examples, the device comprises: a pump light source (e.g., a pump laser); a probe light source (e.g., a probe laser); a single mode fiber circulator; a dichroic beam combiner; an off-axis parabolic mirror; and a detector; the pump light source being configured to provide a pump signal; the off-axis parabolic mirror being configured to receive the pump signal and focus the pump signal onto the sample; the probe light source being configured to provide a probe signal; the single mode fiber circulator being configured to receive the probe signal from the probe light source and transmit the probe signal to the dichroic beam combiner; the dichroic beam combiner being configured to receive the probe signal from the single mode fibercirculator, and transmit the probe signal to the sample; and the dichroic beam combiner being further configured to subsequently receive and transmit a measured signal to the detector.
[0200] In some examples, the device further comprises one or more focusing elements (e.g., collimator, objective, lens, mirror, etc.). In some examples, the device further comprises one or more additional components, such as a beam splitter, a beam circulator, a multi-mode fiber, or a combination thereof.
[0201] In some examples, the device further comprises a movable stage, the sample being supported by the movable stage. In some examples, the device further comprises a means for translocating the movable stage, thereby translocating the sample to thereby provide hyperspectral imaging of a plurality of locations of the sample.
[0202] The pump light source can comprise any suitable type of light source consistent with the devices and methods herein. Examples of suitable light sources include artificial light sources e.g., incandescent light bulbs, light emitting diodes, gas discharge lamps, arc lamps, black body sources, lasers etc.).
[0203] In some examples, the pump light source comprises a light emitting diode (LED).
[0204] In some examples, the pump light source comprises a laser. In some examples, the pump laser comprises a QCL, such as a pulsed QCL.
[0205] In some examples, the pump light source comprises a supercontinuum laser.
[0206] In some examples, the pump light source comprises an OPO laser.
[0207] In some examples, the pump light source comprises a femtosecond laser.
[0208] In some examples, the pump light source comprises a picosecond laser.
[0209] In some examples, the pump light source comprises a comb laser.
[0210] In some examples, the pump light source has a wavelength of 2000 nanometers (nm) or more (e.g., 3000 nm or more; 4000 nm or more; 5000 nm or more; 6000 nm or more; 7000 nm or more; 8000 nm or more; 9000 nm or more; 10,000 nm or more; 12,000 nm or more; 14,000 nm or more; 16,000 nm or more; 18,000 nm or more; 20,000 nm or more; or 22,000 nm or more). In some examples, the pump light source can have a wavelength of 25,000 nm or less (e.g., 24,000 nm or less; 22,000 nm or less; 20,000 nm or less; 18,000 nm or less; 16,000 nm or less; 14,000 nm or less; 12,000 nm or less; 10,000 nm or less; 9000 nm or less; 8000 nm or less; 7000 nm or less; 6000 nm or less; or 5000 nm or less). The wavelength of the pump light source can range from any of the minimum values described above to any of the maximum values described above. For example, the pump light source can have a wavelength of from 2000 nm to 25,000 nm (e.g., from 2000 to 14,000 nm; from 14,000 to 25,000 nm; from 2000 to 24,000 nm; from 3000 to 25,000 nm; from 3000 to 24,000 nm; from 5000 to 20,000 nm; from 3000 to14,000 nm; or from 5000 to 12000 nm). In some examples, the pump light source has a wavelength of from 5000 to 20000 nm, or from 5000 to 12000 nm. In some examples, the pump light source has a wavelength of from 2000 to 12000 nm.
[0211] In some examples, the pump light source has a wavelength in the infrared region of the electromagnetic spectrum, such as the mid-infrared (MIR) region.
[0212] In some examples, the device further comprises a modulator coupled to the pump light source, the waveform generator configured to modulate the pump signal. In some examples, the modulator comprises a waveform generator.
[0213] The probe light source can comprise any suitable type of light source consistent with the devices and methods herein. Examples of suitable light sources include artificial light sources (e.g., incandescent light bulbs, light emitting diodes, gas discharge lamps, arc lamps, black body sources, lasers etc.).
[0214] In some examples, the probe light source comprises a laser.
[0215] In some examples, the probe light source comprises a swept source laser.
[0216] In some examples, the probe light source comprise a broadband laser.
[0217] In some examples, the probe light source comprises a black body source.
[0218] In some examples, the probe light source comprises a light emitting diode (LED).
[0219] In some examples, the probe light source comprises a continuous wave (CW) light source.
[0220] In some examples, the probe light source comprises a pulsed light source.
[0221] In some examples, the probe light source has a wavelength in the ultraviolet, visible, infrared, or other region of the electromagnetic spectrum. In some examples, the probe light source has a wavelength in visible region (e.g., from 400 to 700 nm) of the electromagnetic spectrum. In some examples, the probe light source has a wavelength in the ultraviolet region (e.g., less than 400 nm) of the electromagnetic spectrum. In some examples, the probe light source has a wavelength in the infrared region (e.g., greater than 700 nm) of the electromagnetic spectrum. In some examples, the probe light source has a wavelength in the infrared region of the electromagnetic spectrum, such as the near-infrared (NIR) region.
[0222] In some examples, the device further comprises an optical fiber. The optical fiber can, for example, be used to transmit light.
[0223] In some examples, the optical fiber comprises a chalcogenide fiber.
[0224] In some examples, the optical fiber comprises a single mode fiber.
[0225] In some examples, the optical fiber comprises a multi-mode fiber.
[0226] In some examples the optical fiber comprises a hollow core fiber.In some examples, the optical fiber comprises a photonic crystal fiber.
[0227] In some examples, the optical fiber is a flexible fiber optic.
[0228] In some examples, the device further comprises a light-routing component. For example, the light-routing component can be used to direct light to the detector.
[0229] In some examples, the light-routing component comprises an optical coupler. In some examples, the light-routing component is a fiber coupler. In some examples the light-routing component comprises a free-space coupler. In some examples, the light-routing component can be replaced by a circulator. In some examples, the light-routing component can be replaced by a beam splitter. In some examples, the light-routing component can be replaced by a beam combiner.
[0230] In some examples, the device further comprises a condenser configured to couple the pump signal into the optical fiber. In some examples, the condenser is configured to receive the pump signal from the pump light source and mode match the pump signal with the optical fiber before the pump signal enters the optical fiber.
[0231] In some examples, the condenser is an aspheric condenser.
[0232] In some examples, the condenser is a reflective mirror.
[0233] In some examples, the condenser is a lens. In some examples, the condenser is a set of lenses.
[0234] In some examples, the condenser is an objective.
[0235] In some examples, the condenser is a combination of reflective and refractive components.
[0236] In some examples, the condenser is a Cassegrain objective.
[0237] In some examples, the device further comprises a collimation optic, which can, for example, be used to collimate the pump beam and / or the probe beam.
[0238] In some examples, the device further comprises a fixed focus collimator configured to receive the probe signal from the light-routing component, focus the probe signal, and transmit the focused probe signal to the dichroic beam combiner.
[0239] In some examples, the device further comprises a variable focus collimator configured to receive the probe signal grom the fiber coupler, focus the probe signal, and transmit the focused probe signal to the dichroic beam combiner.
[0240] In some examples, the dichroic beam combiner can be used to combine the pump and probe beams.
[0241] In some examples, the dichroic beam combiner comprises a short-pass dichroic beam combiner.In some examples, the dichroic beam combiner comprises a long-pass dichroic beam combiner.
[0242] In some examples, the dichroic beam combiner is further configured to align the pump signal from the optical fiber and the probe signal from the light-routing component, such as a coupler.
[0243] In some examples, the device further comprises a focusing optic, which can, for example, be used to focus the pump beam and / or the probe beam.
[0244] In some examples, the focusing optic comprises a mirror, such as a curved mirror.
[0245] In some examples, the focusing optic comprises an off-axis parabolic mirror.
[0246] In some examples, the device further comprises a movable stage, the focusing optic being mounted on the movable stage. In some examples, the movable stage comprises a set of cascaded rotational-translation stages. In some examples, the device further comprises a means for translating the movable stage, thereby translocating the focusing optic to thereby provide imaging of a plurality of locations of the sample.
[0247] In some examples, the device further comprises a means for translating the pump light source and / or probe light source, for example laterally, to thereby provide imaging of a plurality of locations of the sample.
[0248] In some examples, light is detected using one or more detectors.
[0249] In some examples, the detector comprises a photodiode.
[0250] In some examples, the detector comprises an array of photodiodes.
[0251] In some examples, the detector comprises an array of detection elements.
[0252] In some examples, the detector comprises a camera system.
[0253] In some examples, a curved mirror focuses the pump beam on to the sample.
[0254] In some examples, the pump and probe beams have different optical paths, but are focused on the same region of the sample.
[0255] In some examples, the pump and probe beam are combined before they reach the sample. In some examples, the device further comprises a computing device operably coupled to one or more device components.
[0256] The sample can comprise any sample consistent with the methods and devices described herein. In some examples, the sample comprises a biological sample. In some examples, the sample comprises tissue. In some examples, the sample comprises ovarian tissue, endometrial tissue, cervical tissue, kidney tissue (e.g., kidney tissue features such as tubules and glomeruli), bone marrow tissue, brain tissue (e.g., neuronal bundles in the brain), or a combination thereof. In some examples, the sample comprises collagen. In some examples, the sample comprisesliving cells, and the method is performed in situ on living cells. In some examples, the device enables in vivo label-free imaging of biological tissue. In some examples, the device is configured to be coupled to an endoscope to provide in situ imaging of biological tissue.
[0257] In some examples, the sample comprises inorganic compounds.
[0258] In some examples, the device enables label free characterization of inorganic and organic material.
[0259] In some examples, the sample comprises a polymer. In some examples, the sample comprises polystyrene, poly(methyl methacrylate) (PMMA), or a combination thereof.
[0260] In some examples, the sample comprises battery materials. In some examples, the sample comprises solar panel materials. In some examples, the sample comprises materials used in energy research. In some examples, the sample comprises organic materials. In some examples, the sample comprises unknown chemicals of interest. In some examples, the sample comprises composite materials. In some examples, the sample comprises materials used in art. In some examples, the sample comprises historical artifacts and documents. In some examples, the sample comprises diagnostically relevant constituents. In some examples, the sample comprises a combination of multiple materials. In some examples, the sample comprises heterogeneous structures. In some examples, the sample comprises liquids and gases. In some examples, the sample comprises oils.
[0261] In some examples, the sample comprises neuronal bundles in the brain. In some examples, the sample comprises kidney tissue features such as tubules and glomeruli.
[0262] In some examples, the device can be diagnostically useful.
[0263] In some examples, the device provides structural and chemical information.
[0264] In some examples, the device provides molecular information relevant for disease analysis.
[0265] In some examples, the device being as shown in Figure 4.
[0266] In some examples, the device couples photothermal mid-infrared spectroscopy to optical coherence tomography, such as Fourier-domain optical coherence tomography.
[0267] In some examples, the device combines the high-resolution structural imaging of optical coherence tomography (OCT) with the biochemical contrast of mid-infrared photothermal detection.
[0268] In some examples, the device is configured such that optical coherence tomography is leveraged to provide a common path interferometry for photothermal microscopy.
[0269] In some examples, the device has subcellular resolution.
[0270] In some examples, the device is a point-of-care device.In some examples, the device can provide 3D structural information
[0271] In some examples, the device can provide chemical information.
[0272] In some examples, the device can provide simultaneous 3D and chemical information. In some examples, the device can provide diagnostically relevant molecular information. In some examples, the device is configured to be handheld.
[0273] In some examples, the device is portable.
[0274] In some examples, the device is flexible.
[0275] In some examples, the device is easy to use.
[0276] In some examples, the device can provide immediate feedback.
[0277] In some examples, the device can provide diagnostic information.
[0278] In some examples, the device can assist with real-time analysis.
[0279] In some examples, the device can be in contact with humans in a safe manner.
[0280] In some examples, the device can provide label-free contrast.
[0281] In some examples, the device is miniaturized and compact.
[0282] Also disclosed herein are methods of use of any of the devices described herein. In some examples, the methods comprise using the devices to perform any of the methods described herein.
[0283] In some examples, the method comprises using the device in a clinical or field setting. In some examples, the method comprises using the device in a point-of-care setting. In some examples, the methods can comprise using the device in a hospital, clinical setting, field application in the plastics and materials industries, or a combination thereof.
[0284] In some examples, the method comprises using the device in a biomedical setting or application.
[0285] In some examples, the method comprises using the device for biological research, clinical diagnostics, or a combination thereof.
[0286] In some examples, the method comprises using the device for diagnostic imaging of complex biological systems.
[0287] In some examples, the method further comprises collecting the sample.
[0288] In some examples, the method comprises diagnosing and / or monitoring a condition or disease in a subject based on a property of the sample.
[0289] In some examples, the method comprises using the device in biomedical and / or clinical applications, for example for disease visualization and diagnosis.
[0290] In some examples, the method comprises using the device to provide rapid diagnosis at a point of care and / or clinical setting.In some example, the method is minimally invasive.
[0291] In some example, the method is non-invasive.
[0292] In some examples, the method further comprises selecting a course of therapy for the subject based on the property of the sample.
[0293] In some examples, the methods can comprise using the device for material characterization.
[0294] In some examples, the methods can comprise using the device for field characterization of oil samples.
[0295] In some examples, the methods can comprise using the device for energy research.
[0296] In some examples, the methods can comprise using the device for battery characterization.
[0297] In some examples, the methods can comprise using the device for solar panel characterization.
[0298] In some examples, the methods can comprise using the device for field identification of hazardous materials.
[0299] In some examples, the methods can comprise using the device for field identification of unknown chemicals.
[0300] In some examples, the methods can comprise using the device for field identification of historical artifacts.
[0301] Spectroscopic Imaging Devices, Systems, and Methods
[0302] Described herein are spectroscopic imaging devices, systems, and methods.
[0303] For example, described herein are spectroscopic imaging devices. The spectroscopic imaging devices comprise: a pump light source (e.g., laser); a probe light source (e.g., laser); an optical fiber (e.g., a single mode fiber); a light-routing component (e.g., a fiber coupler); a dichroic beam combiner; a collimation optic (e.g., a reflective collimator); a focusing optic (e.g., an off-axis parabolic mirror); and a detector.
[0304] The pump light source is configured to provide a pump signal. The optical fiber is configured to receive the pump signal from the pump light source and transmit the pump signal to a dichroic beam combiner. The probe light source is configured to provide a probe signal. The light-routing component is configured to receive the probe signal from the probe light source and transmit the probe signal to the dichroic beam combiner. The collimation optic is configured to receive the pump signal from the optical fiber and transmit the pump signal to the dichroic beam combiner. The dichroic beam combiner is configured to receive and combine the pump signal from the collimation optic and the probe signal from the light-routing component, and transmitthe combined signal to the focusing optic. The focusing optic is configured to receive the combined signal and focus the combined signal onto a sample, and subsequently transmit a measured signal back through the dichroic beam combiner to the light-routing component and then to a detector. The device is configured to: irradiate at least a portion of a sample at a location with a pump signal, thereby inducing a photothermal response in the sample, and subsequently detect and analyze a signal from a probe signal that simultaneously illuminates at least the portion of the sample, wherein the photothermal response induced by the pump signal is transferred to the probe signal, which is subsequently photodetected as a signal that is analyzed to thereby provide imaging of the sample.
[0305] In some examples, the device further comprises one or more focusing elements (e.g., collimator, objective, lens, mirror, etc.). In some examples, the device further comprises one or more additional components, such as a beam splitter, a beam circulator, a multi-mode fiber, or a combination thereof.
[0306] In some examples, the device further comprises a movable stage, the sample being supported by the movable stage. In some examples, the device further comprises a means for translocating the movable stage, thereby translocating the sample to thereby provide imaging of a plurality of locations of the sample.
[0307] The pump light source can comprise any suitable type of light source consistent with the devices and methods herein. Examples of suitable light sources include artificial light sources e.g., incandescent light bulbs, light emitting diodes, gas discharge lamps, arc lamps, black body sources, lasers etc.). In some examples, the pump light source comprises a black body source.
[0308] In some examples, the pump light source comprises a light emitting diode (LED).
[0309] In some examples, the pump light source comprises a laser. In some examples, the pump laser comprises a QCL, such as a pulsed QCL.
[0310] In some examples, the pump light source comprises a supercontinuum laser.
[0311] In some examples, the pump light source comprises an OPO laser.
[0312] In some examples, the pump light source comprises a femtosecond laser.
[0313] In some examples, the pump light source comprises a picosecond laser.
[0314] In some examples, the pump light source comprises a comb laser.
[0315] The pump light source can, for example, have a wavelength of 2000 nanometers (nm) or more (e.g., 3000 nm or more; 4000 nm or more; 5000 nm or more; 6000 nm or more; 7000 nm or more; 8000 nm or more; 9000 nm or more; 10,000 nm or more; 12,000 nm or more; 14,000 nm or more; 16,000 nm or more; 18,000 nm or more; 20,000 nm or more; or 22,000 nm or more). In some examples, the pump light source can have a wavelength of 25,000 nm or less(e.g., 24,000 nm or less; 22,000 nm or less; 20,000 nm or less; 18,000 nm or less; 16,000 nm or less; 14,000 nm or less; 12,000 nm or less; 10,000 nm or less; 9000 nm or less; 8000 nm or less; 7000 nm or less; 6000 nm or less; or 5000 nm or less). The wavelength of the pump light source can range from any of the minimum values described above to any of the maximum values described above. For example, the pump light source can have a wavelength of from 2000 to 25,000 nm (e.g., from 2000 to 14,000 nm; from 14,000 to 25,000 nm; from 2000 to 24,000 nm; from 3000 to 25,000 nm; from 3000 to 24,000 nm; from 5000 to 20,000 nm; from 3000 to 14,000 nm; or from 5000 to 12000 nm). In some examples, the pump light source has a wavelength of from 5000 to 20000 nm, or from 5000 to 12000 nm. In some examples, the pump light source has a wavelength of from 2000 to 12000 nm.
[0316] In some examples, the pump light source has a wavelength in the infrared region of the electromagnetic spectrum, such as the mid-infrared region.
[0317] In some examples, the device further comprises a modulator coupled to the pump light source, the waveform generator configured to modulate the pump signal. In some examples, the modulator comprises a waveform generator.
[0318] The probe light source can comprise any suitable type of light source consistent with the devices and methods herein. Examples of suitable light sources include artificial light sources e.g., incandescent light bulbs, light emitting diodes, gas discharge lamps, arc lamps, black body sources, lasers etc.).
[0319] In some examples, the probe light source comprises a laser.
[0320] In some examples, the probe light source comprises a black body source.
[0321] In some examples, the probe light source comprises a light emitting diode (LED).
[0322] In some examples, the probe light source comprises a continuous wave (CW) light source.
[0323] In some examples, the probe light source comprises a pulsed light source.
[0324] The probe light source can, for example, have a wavelength in the ultraviolet, visible, infrared, or other region of the electromagnetic spectrum. In some examples, the probe light source has a wavelength in visible region (e.g., from 400 to 700 nm) of the electromagnetic spectrum. In some examples, the probe light source has a wavelength in the ultraviolet region (e.g., less than 400 nm) of the electromagnetic spectrum. In some examples, the probe light source has a wavelength in the infrared region (e.g., greater than 700 nm) of the electromagnetic spectrum.
[0325] In some examples, the optical fiber comprises a chalcogenide fiber.
[0326] In some examples, the optical fiber comprises a single mode fiber. In some examples, thesingle mode fiber comprises a mid-infrared (MIR) chalcogenide single mode fiber.
[0327] In some examples, the optical fiber comprises a multi-mode fiber.
[0328] In some examples the optical fiber comprises a hollow core fiber.
[0329] In some examples, the optical fiber comprises a photonic crystal fiber.
[0330] In some examples, the optical fiber is a flexible fiber optic.
[0331] In some examples, the light-routing component comprises an optical coupler. In some examples, the light-routing component is a fiber coupler. In some examples the light-routing component comprises a free-space coupler. In some examples, the light-routing component can be replaced by a circulator. In some examples, the light-routing component can be replaced by a beam splitter. In some examples, the light-routing component can be replaced by a beam combiner.
[0332] In some examples, the device further comprises a condenser configured to couple the pump signal into the optical fiber. In some examples, the condenser is configured to receive the pump signal from the pump light source and mode match the pump signal with the optical fiber before the pump signal enters the optical fiber.
[0333] In some examples, the condenser is an aspheric condenser.
[0334] In some examples, the condenser is a reflective mirror.
[0335] In some examples, the condenser is a lens. In some examples, the condenser is a set of lenses.
[0336] In some examples, the condenser is an objective.
[0337] In some examples, the condenser is a combination of reflective and refractive components.
[0338] In some examples, the condenser is a Cassegrain objective.
[0339] In some examples, the device further comprises a fixed focus collimator configured to receive the probe signal from the light-routing component, focus the probe signal, and transmit the focused probe signal to the dichroic beam combiner.
[0340] In some examples, the device further comprises a variable focus collimator configured to receive the probe signal grom the fiber coupler, focus the probe signal, and transmit the focused probe signal to the dichroic beam combiner.
[0341] In some examples, the dichroic beam combiner comprises a short-pass dichroic beam combiner.
[0342] In some examples, the dichroic beam combiner comprises a long-pass dichroic beam combiner.
[0343] In some examples, the dichroic beam combiner is further configured to align the pumpsignal from the optical fiber and the probe signal from the light-routing component.
[0344] In some examples, the focusing optic comprises an off-axis parabolic mirror.
[0345] In some examples, the device further comprises a movable stage, the focusing optic being mounted on the movable stage. In some examples, the movable stage comprises a set of cascaded rotational-translation stages. In some examples, the device further comprises a means for translating the movable stage, thereby translocating the focusing optic to thereby provide imaging of a plurality of locations of the sample.
[0346] In some examples, the device further comprises a means for translating the pump light source and / or probe light source, for example laterally, to thereby provide imaging of a plurality of locations of the sample.
[0347] In some examples, the detector comprises a photodiode.
[0348] In some examples, the detector comprises an array of photodiodes.
[0349] In some examples, the detector comprises an array of detection elements.
[0350] In some examples, the detector comprises a camera system.
[0351] In some examples, the spectroscopic imaging devices comprise: a pump laser; a probe laser; a single mode fiber; a fiber coupler; a dichroic beam combiner; a reflective collimator; an off-axis parabolic mirror; and a detector.
[0352] The pump laser is configured to provide a pump signal. The single mode fiber is configured to receive the pump signal from the pump laser and transmit the pump signal to a dichroic beam combiner. The probe laser is configured to provide a probe signal. The fiber coupler is configured to receive the probe signal from the probe laser and transmit the probe signal to the dichroic beam combiner. The reflective collimator is configured to receive the pump signal from the single mode fiber and transmit the pump signal to the dichroic beam combiner. The dichroic beam combiner is configured to receive and combine the pump signal from the reflective collimator and the probe signal from the fiber coupler, and transmit the combined signal to the off-axis parabolic mirror. The off-axis parabolic mirror is configured to receive the combined signal and focus the combined signal onto a sample, and subsequently transmit a measured signal back through the dichroic beam combiner to the fiber coupler and then to a detector. The device is configured to: irradiate at least a portion of a sample at a location with a pump signal, thereby inducing a photothermal response in the sample, and subsequently detect and analyze a signal from a probe signal that simultaneously illuminates at least the portion of the sample, wherein the photothermal response induced by the pump signal is transferred to the probe signal, which is subsequently photodetected as a signal that is analyzed to thereby provide imaging of the sample.In some examples, the device further comprises a computing device operably coupled to one or more device components.
[0353] The sample can comprise any sample consistent with the methods and devices described herein. In some examples, the sample comprises a biological sample. In some examples, the sample comprises tissue. In some examples, the sample comprises ovarian tissue, endometrial tissue, cervical tissue, kidney tissue, bone marrow tissue, brain tissue, or a combination thereof. In some examples, the sample comprises collagen. In some examples, the device enables in vivo label-free imaging of biological tissue. In some examples, the device is configured to be coupled to an endoscope to provide in situ imaging of biological tissue.
[0354] In some examples, the sample comprises inorganic compounds.
[0355] In some examples, the device enables label free characterization of inorganic and organic material.
[0356] In some examples, the sample comprises a polymer. In some examples, the sample comprises polystyrene, poly(methyl methacrylate) (PMMA), or a combination thereof.
[0357] In some examples, the sample comprises battery materials. In some examples, the sample comprises solar panel materials. In some examples, the sample comprises materials used in energy research. In some examples, the sample comprises organic materials. In some examples, the sample comprises unknown chemicals of interest. In some examples, the sample comprises composite materials. In some examples, the sample comprises materials used in art. In some examples, the sample comprises historical artifacts and documents. In some examples, the sample comprises diagnostically relevant constituents. In some examples, the sample comprises a combination of multiple materials. In some examples, the sample comprises heterogeneous structures. In some examples, the sample comprises liquids and gases. In some examples, the sample comprises oils.
[0358] In some examples, the device being as shown in Figure 11.
[0359] In some examples, the device comprises a photothermal mid-infrared spectroscopic imaging device.
[0360] In some examples, the device is compact.
[0361] In some examples, the device is smaller than a traditional bench-top device.
[0362] In some examples, the device has a footprint that is 10 sq. ft or less in size (e.g., 9 sq. ft or less, 8 sq. ft or less, 7 sq. ft or less, 6 sq. ft or less, 5 sq. ft or less, 4 sq. ft or less, 3 sq. ft or less, 2 sq. ft or less, 1 sq. ft or less, 0.75 sq. ft or less, 0.5 sq. ft or less, or 0.25 sq. ft or less). In some examples, the device has a footprint that is 4 sq. ft or less in size. In some examples, the device has a footprint that is 2 sq. ft. or less in size.In some examples, the device has subcellular resolution.
[0363] In some examples, the device has comparable or better performance than a state-of-the-art benchtop system.
[0364] In some examples, the device is configured to be handheld.
[0365] In some examples, the device is portable.
[0366] In some examples, the device is a point-of-care device.
[0367] In some examples, the device is flexible.
[0368] In some examples, the device is easy to use.
[0369] In some examples, the device can provide immediate feedback.
[0370] In some examples, the device can provide diagnostic information.
[0371] In some examples, the device can assist with real-time analysis.
[0372] In some examples, the device can be in contact with humans in a safe manner.
[0373] In some examples, the device can provide label-free contrast.
[0374] Also described herein are methods of use of any of the devices described herein.
[0375] For example, the methods can comprise using the device in a clinical or field setting. In some examples, the methods can comprise using the device in a point-of-care setting. In some examples, the methods can comprise using the device in a hospital, clinical setting, field application in the plastics and materials industries, or a combination thereof.
[0376] In some examples, the method can comprise using the device in a biomedical setting or application.
[0377] In some examples, the methods can further comprise collecting the sample.
[0378] In some examples, the methods can comprise diagnosing and / or monitoring a condition or disease in a subject based on a property of the sample.
[0379] In some examples, the methods are non-invasive.
[0380] In some examples, the methods can further comprise selecting a course of therapy for the subject based on the property of the sample.
[0381] In some examples, the methods can comprise using the device for material characterization.
[0382] In some examples, the methods can comprise using the device for field characterization of oil samples.
[0383] In some examples, the methods can comprise using the device for energy research. In some examples, the methods can comprise using the device for battery characterization.
[0384] In some examples, the methods can comprise using the device for solar panelcharacterization.
[0385] In some examples, the methods can comprise using the device for field identification of hazardous materials.
[0386] In some examples, the methods can comprise using the device for field identification of unknown chemicals.
[0387] In some examples, the methods can comprise using the device for field identification of historical artifacts.
[0388] Also disclosed herein are spectroscopic imaging method, for example using any of the devices described herein.
[0389] In some examples, the methods comprise: irradiating at least a portion of the sample at a location with the pump signal from a pump light source, thereby inducing a photothermal response in the sample; and subsequently detecting and analyzing a probe signal from the probe light source that simultaneously illuminates the sample; wherein the photothermal response induced by the pump signal is transferred to the probe signal, which is subsequently photodetected as a signal that is analyzed to thereby provide imaging of the sample.
[0390] In some examples, the methods further comprise translocating the sample and / or at least a portion of the device to thereby provide imaging of a plurality of locations of the sample.
[0391] In some examples, the sample comprises living cells, and the method is performed in situ on living cells.
[0392] In some examples, the method comprises photothermal mid-infrared spectroscopy. In some examples, the method is label-free.
[0393] In some examples, the method is substantially free of any added contrast agents.
[0394] In some examples, the method has subcellular resolution.
[0395] Computing device
[0396] Figure 5 illustrates an example computing device 240 upon which examples disclosed herein may be implemented. The computing device 240 can include a bus or other communication mechanism for communicating information among various components of the computing device 240. In its most basic configuration, computing device 240 typically includes at least one processing unit 242 (a processor) and system memory 244. Depending on the exact configuration and type of computing device, system memory 244 may be volatile (such as random access memory (RAM)), non-volatile (such as read-only memory (ROM), flash memory, etc.), or some combination of the two. This most basic configuration is illustrated in Figure 5 by a dashed line 246. The processing unit 242 may be a standard programmableprocessor that performs arithmetic and logic operations necessary for operation of the computing device 240.
[0397] The computing device 240 can have additional features / functionality. For example, computing device 240 may include additional storage such as removable storage 250 and nonremovable storage 252 including, but not limited to, magnetic or optical disks or tapes. The computing device 240 can also contain network connection(s) 258 that allow the device to communicate with other devices. The computing device 240 can also have input device(s) 256 such as a keyboard, mouse, touch screen, antenna or other systems configured to communicate with the camera in the system described above, etc. Output device(s) 254 such as a display, speakers, printer, etc. may also be included. The additional devices can be connected to the bus in order to facilitate communication of data among the components of the computing device 240.
[0398] The processing unit 242 can be configured to execute program code encoded in tangible, computer-readable media. Computer-readable media refers to any media that is capable of providing data that causes the computing device 240 ( / .< ., a machine) to operate in a particular fashion. Various computer-readable media can be utilized to provide instructions to the processing unit 242 for execution. Common forms of computer-readable media include, for example, magnetic media, optical media, physical media, memory chips or cartridges, a carrier wave, or any other medium from which a computer can read. Example computer-readable media can include, but is not limited to, volatile media, non-volatile media and transmission media. Volatile and non-volatile media can be implemented in any method or technology for storage of information such as computer readable instructions, data structures, program modules or other data and common forms are discussed in detail below. Transmission media can include coaxial cables, copper wires and / or fiber optic cables, as well as acoustic or light waves, such as those generated during radio-wave and infra-red data communication. Example tangible, computer-readable recording media include, but are not limited to, an integrated circuit (e.g., field-programmable gate array or application-specific IC), a hard disk, an optical disk, a magnetooptical disk, a floppy disk, a magnetic tape, a holographic storage medium, a solid-state device, RAM, ROM, electrically erasable program read-only memory (EEPROM), flash memory or other memory technology, CD-ROM, digital versatile disks (DVD) or other optical storage, magnetic cassettes, magnetic tape, magnetic disk storage or other magnetic storage devices.
[0399] In an example implementation, the processing unit 242 can execute program code stored in the system memory 244. For example, the bus can carry data to the system memory 244, from which the processing unit 242 receives and executes instructions. The data received by the system memory 244 can optionally be stored on the removable storage 250 or the non-removablestorage 252 before or after execution by the processing unit 242.
[0400] The computing device 240 typically includes a variety of computer-readable media. Computer-readable media can be any available media that can be accessed by device 240 and includes both volatile and non-volatile media, removable and non-removable media. Computer storage media include volatile and non-volatile, and removable and non-removable media implemented in any method or technology for storage of information such as computer readable instructions, data structures, program modules or other data. System memory 244, removable storage 250, and non-removable storage 252 are all examples of computer storage media.
[0401] Computer storage media include, but are not limited to, RAM, ROM, electrically erasable program read-only memory (EEPROM), flash memory or other memory technology, CD-ROM, digital versatile disks (DVD) or other optical storage, magnetic cassettes, magnetic tape, magnetic disk storage or other magnetic storage devices, or any other medium which can be used to store the desired information and which can be accessed by computing device 240. Any such computer storage media can be part of computing device 240.
[0402] It should be understood that the various techniques described herein can be implemented in connection with hardware or software or, where appropriate, with a combination thereof. Thus, the methods, systems, and associated signal processing of the presently disclosed subject matter, or certain aspects or portions thereof, can take the form of program code ( / .< ., instructions) embodied in tangible media, such as floppy diskettes, CD-ROMs, hard drives, or any other machine-readable storage medium wherein, when the program code is loaded into and executed by a machine, such as a computing device, the machine becomes an apparatus for practicing the presently disclosed subject matter. In the case of program code execution on programmable computers, the computing device generally includes a processor, a storage medium readable by the processor (including volatile and non-volatile memory and / or storage elements), at least one input device, and at least one output device. One or more programs can implement or utilize the processes described in connection with the presently disclosed subject matter, e.g., through the use of an application programming interface (API), reusable controls, or the like. Such programs can be implemented in a high level procedural or object-oriented programming language to communicate with a computer system. However, the program(s) can be implemented in assembly or machine language, if desired. In any case, the language can be a compiled or interpreted language and it may be combined with hardware implementations.
[0403] The analysis of signals captured by the instrument and / or device can be carried out in whole or in part on one or more computing device. For example, the system may comprise one or more additional computing device.A number of embodiments of the invention have been described. Nevertheless, it will be understood that various modifications may be made without departing from the spirit and scope of the invention. Accordingly, other embodiments are within the scope of the following claims.
[0404] The examples below are intended to further illustrate certain aspects of the systems and methods described herein, and are not intended to limit the scope of the claims.
[0405] EXAMPLES
[0406] The following examples are set forth below to illustrate the methods and results according to the disclosed subject matter. These examples are not intended to be inclusive of all aspects of the subject matter disclosed herein, but rather to illustrate representative methods and results. These examples are not intended to exclude equivalents and variations of the present invention which are apparent to one skilled in the art.
[0407] Efforts have been made to ensure accuracy with respect to numbers (e.g., amounts, temperature, etc.) but some errors and deviations should be accounted for. Unless indicated otherwise, parts are parts by weight, temperature is in °C or is at ambient temperature, and pressure is at or near atmospheric. There are numerous variations and combinations of measurement conditions, e.g., component concentrations, temperatures, pressures and other measurement ranges and conditions that can be used to optimize the described process.
[0408] Example 1- Label-free chemical contrast in optical coherence tomography using photothermal mid-infrared spectroscopic imaging
[0409] Described herein is a label-free mid-infrared photothermal optical coherence tomography (MIP-OCT) imaging system that combines the high-resolution structural imaging of optical coherence tomography (OCT) with the biochemical contrast of mid-infrared photothermal detection. By leveraging advancements in Fourier-domain OCT (FD-OCT) and mid-infrared photothermal techniques, the system described herein addresses the limitations of conventional OCT, which provides structural information without biochemical specificity, and overcomes challenges in previous photothermal implementations.
[0410] The MIP-OCT system is validated using a 1951 USAF resolution target to ensure spatial alignment and system accuracy. Spatial and spectral fidelity are demonstrated with polystyrene beads of varying diameters (25 pm and 45 pm). The system's capability is further demonstrated on biological tissues, imaging collagen structures in thin mouse kidney slices and detecting myelinated axons in thicker mouse brain sections.
[0411] This innovation bridges the gap between structural and biochemical imaging, enabling label-free, high-resolution imaging with potential applications in basic biological research and clinical diagnostics. By integrating biochemical contrast with the clinically relevant and versatileform of OCT, MIP-OCT offers a transformative tool for advancing diagnostic imaging and understanding complex biological systems.
[0412] OCT is a label-free three dimensional (3D) imaging technology used extensively in biomedical and clinical applications for disease visualization and diagnosis. However, it visualizes tissue structure (morphology) but not its molecular properties. Herein, OCT is combined with a label-free biochemically sensitive technology, namely photothermal midinfrared spectroscopic imaging, that adds label-free molecular contrast to OCT. This enables rapid diagnosis at the point of care and clinical settings. The resulting technology provides both 3D and molecular information, both without the addition of external contrast agents. This makes the technology easy to use in disease diagnosis in a minimally invasive manner. This technology can be used as an endoscopic device that rapidly and accurately performs diagnosis.
[0413] The field of label -free diagnostics can benefit from this technology that provides both 3D and molecular information. This would allow faster and more accurate diagnosis at the point of care. The diagnostic process could also be completely automated through the integration of artificial intelligence algorithms in the future.
[0414] This innovation addresses a longstanding gap in the state-of-the-art in OCT. OCT provides structure, but not molecular information. Described herein is a new way of providing diagnostically relevant molecular information through photothermal mid-infrared spectroscopic imaging. OCT is utilized as a probe for photothermal mid-infrared spectroscopic imaging, thus producing co-registered data that is diagnostically useful. This can be further combined with artificial intelligence algorithms for automated and fast diagnosis. Current methods require long wait times to obtain diagnostic results.
[0415] This innovation is an important step in making disease diagnosis rapid, accurate and at the point of care. This is a significant improvement over current methods which could require days to weeks of wait time for getting diagnostic results.
[0416] Example 2 - Label-free chemical contrast in optical coherence tomography using photothermal mid-infrared spectroscopy
[0417] Abstract. Presented herein is a label-free mid-infrared photothermal optical coherence tomography (MIP-OCT) imaging system that combines the high-resolution structural imaging of optical coherence tomography (OCT) with the biochemical contrast of mid-infrared photothermal detection. By leveraging advancements in Fourier-domain OCT (FD-OCT) and mid-infrared photothermal techniques, the system described herein addresses the limitations of conventional OCT, which provides structural information without biochemical specificity, and overcomes challenges in previous photothermal implementations. The MIP-OCT system isvalidated using a 1951 USAF resolution target to ensure spatial alignment and system accuracy. Spatial and spectral fidelity are demonstrated with polystyrene beads of varying diameters (25 pm and 45 pm). The system’s capability is further demonstrated on biological tissues, imaging collagen structures in thin mouse kidney slices and detecting myelinated axons in thicker mouse brain sections. This innovation bridges the gap between structural and biochemical imaging, enabling label-free, high-resolution imaging with potential applications in basic biological research and clinical diagnostics. By integrating biochemical contrast with the clinically relevant and versatile form of OCT, MIP-OCT offers a transformative tool for advancing diagnostic imaging and understanding complex biological systems.
[0418] Introduction. Optical Coherence Tomography (OCT) is a non-invasive imaging technique that uses low-coherence light to capture high-resolution, cross-sectional images of biological tissues [1], Technological advancements have significantly enhanced the performance of OCT across multiple dimensions. Resolution has been significantly enhanced, now approaching the level of detail seen in histopathology, providing much finer tissue imaging [2, 3], The shift from time-domain OCT (TD-OCT) to Fourier-domain OCT (FD-OCT) [4, 5] has dramatically boosted imaging speed and sensitivity, allowing for real-time and precise detection of tissue structures [6], Additionally, the advancement of new light sources and faster sensors has increased acquisition speed to several hundred thousand A-scans per second [7], These breakthroughs have opened exciting new possibilities for both detailed tissue structure imaging and the visualization of dynamic tissue processes. However, OCT has limitations in diagnostic specificity. Conventional OCT primarily generates structural images based on light scattering differences, which only provide information about the morphology of tissues. This structural data is a nonspecific biomarker and cannot distinguish between different tissue types, making it less effective in identifying the precise nature of certain diseases.
[0419] Label-free imaging modalities, such as vibrational microscopy, are essential tools in biomedical research and diagnostics, providing high chemical specificity without the use of exogenous contrast agents [8, 9], Techniques like second harmonic generation (SHG)
[0010] , Raman spectroscopy
[0011] , and infrared (IR) imaging
[0012] exploit intrinsic molecular vibrations and electronic transitions in biological samples but face several limitations. SHG offers high contrast but is limited to non-centrosymmetric structures like collagen and requires a high numerical aperture [10, 13], Raman spectroscopy, while sensitive to molecular vibrations, suffers from weak signal strength, necessitating long integration times, and although coherent Raman methods enhance signal levels, they are still restricted by a small absorption crosssection [11, 14, 15], IR imaging methods, such as Fourier transform infrared spectroscopy(FTIR), offer higher sensitivity due to larger absorption cross-sections, but their spatial resolution is compromised by the long IR wavelengths [16-18], Mid-infrared photothermal (MIP) imaging has emerged as a promising alternative for addressing these challenges. In MIP, a mid-infrared (MIR) pump beam excites the vibrational modes of the sample. As the sample returns to equilibrium through non-radiative relaxation, it undergoes a localized temperature change. This temperature variation leads to thermal expansion and an alteration in the refractive index of the material, which is subsequently detected by a probe beam. A visible-range probe beam was initially employed and demonstrated to be effective by combining the sensitivity of mid-infrared absorption with the high spatial resolution of visible light
[0019] , Beyond this approach, various detection mechanisms for MIP, such as photoacoustic (PA) imaging [20, 21], quantitative phase
[0022] , and intensity diffraction tomography (IDT)
[0023] , have been explored, further enhancing its versatility. Integrating MIP with complementary techniques unlocks new possibilities, improving sensitivity, resolution, and providing additional pathways for the characterization of complex samples.
[0420] OCT has been extensively adapted and extended for various functional imaging purposes. These functional extensions go beyond the traditional structural imaging capabilities of OCT and provide additional information about biological tissues. Optical coherence elastography (OCE) [24-26] measures tissue stiffness by detecting small deformations in response to mechanical stress or strain and has been used in fields like oncology and dermatology for more accurate diagnostics [27, 28], Doppler OCT combines the Doppler principle with OCT
[0029] , extending OCT’s functionality to measure blood flow by detecting phase shifts caused by red blood cell movement [30, 31], and provides high-resolution, non-invasive imaging of blood flow in real-time. It’s valuable for assessing microvascular function in tissues such as the retina and skin [32, 33], The need for biochemical contrast in OCT has been widely recognized as important. Spectroscopic OCT has been an attempt to introduce chemical contrast [34, 35], However, these configurations use near-infrared (NIR) light where biological samples exhibit minimal intrinsic absorption, limiting the broader application of the technique. Previous approaches to utilize the photothermal effect in combination with OCT have relied on extrinsic contrast agents [35-37], This reliance diminishes the label-free nature of OCT measurements. In addition, contrast agents that go into the human body are challenging to develop as they impose stringent safety and efficacy criteria that are not easily met. A recent study successfully demonstrated Label-free MIR contrast in FF-OCT by utilizing photothermal effect
[0038] , However, this approach is constrained by a limited field of view (FOV) and presents significant challenges in clinical translation. A significant advantage of FD-OCT is its ability tobe made into miniaturized endoscopic devices in point scanning mode. The approach described herein is the first to combine the photothermal effect with the most versatile and clinically relevant form of OCT. It provides biochemical contrast to OCT in a label-free manner and overcomes the challenges with previous approaches.
[0421] Herein, a label-free mid-infrared photothermal optical coherence tomography (MIP-OCT) imaging system is presented that integrates the high-resolution structural imaging of OCT with the biochemical contrast provided by mid-infrared photothermal detection. The system was first validated using a 1951 USAF resolution target, generating co-registered OCT en face and MIP images to confirm spatial alignment and system accuracy. Next, the spatial and spectral fidelity of the system was assessed using polystyrene beads with diameters of 25 pm and 45 pm. Finally, the system’s capability was demonstrate on biomedical samples: first, using thin slices of mouse kidney tissue to visualize collagen structures, and then with thicker sections of mouse brain tissue to detect myelinated axons. This work highlights the potential of MIP-OCT as a powerful tool for label-free biochemical imaging, offering new insights for both basic biological research and clinical diagnostics.
[0422] Results and Discussion. To evaluate the performance of the combined MIP-OCT system, two samples were tested: a custom USAF resolution target and a commercially available Arden OCT phantom. The results of these tests are presented in Figure 1. Figure 1(A) shows the bright-field microscope image of the USAF resolution target, while Figure 1(D) displays the corresponding benchtop mid-infrared photothermal (MIP) image. The OCT en face image of the target is shown in Figure 1(B), and the corresponding MIP image is presented in Figure 1(C). In the OCT en face image (Figure IB), the smallest resolvable feature is Group 5, Element 5, which corresponds to a lateral resolution of 20 pm for the OCT subsystem. In the MIP image (Figure 1C), the smallest resolvable feature is Group 6, Element 1, corresponding to a lateral resolution of 15.6 pm for the MIP subsystem. These results demonstrate that both the OCT and MIP subsystems provide high spatial resolution, with MIP showing slightly finer lateral resolution. The Arden OCT phantom contains 8 layers of resolution target patterns, each separated by 75 pm in depth. Each layer contains a series of groups with 11 lines and spaces, with index lines (marked as m) separating each group. This phantom allows for the characterization of the system’s lateral resolution at different imaging depths. Figure 1(E) illustrates a volumetric scan of the phantom, highlighting the system’s capability for depth-resolved imaging. Figure 1(F) shows both a B-scan and an en face image of the phantom, with the smallest resolvable line space being Group 2, Lines 9 and 10, corresponding to a lateral resolution of 21 pm. This lateral resolution is consistent with the expected spot size of 21 pm, as determined by the near-infrared(NIR) objective used in the system. These measurements of lateral resolution from both the USAF target and the Arden OCT phantom align with the theoretical expectations based on the system’s optical design, validating the system’s spatial fidelity across both structural and chemical imaging modalities.
[0423] The spatial and spectral fidelity of the system described herein was further shown by imaging polystyrene (PS) beads; the results are shown in Figure 2. Figure 2A shows the brightfield image of the 25 pm PS beads acquired using the Bysler camera, used to precisely localize the region of interest (ROI) for subsequent imaging modalities. Figure 2B presents the corresponding en face image obtained from the common-path OCT, which provides depth-resolved structural information. Figure 2C shows the MIP image at the wavenumber 1660 cm’1, highlighting the chemical signature of PS bead. These images demonstrate that the system can provide high-quality spatial and chemical mapping for 25 pm beads. For 45 pm PS beads, similar results were observed. Figure 2D shows the brightfield image from the Bysler camera, while Figure 2E presents the OCT en face image. The corresponding MIP image at 1660 cm’1is displayed in Figure 2F. In addition to spatial imaging, the spectral performance of the system was also evaluated by comparing the PS spectrum obtained from the system described herein to that from a commercial MIRAGE system. Figure 2G presents the PS spectrum, measured at a resolution of 0.5 cm’1and averaged over 5 spectral acquisitions. The characteristic PS peaks, including the absorption at 1660 cm’1, are evident and show strong agreement with the spectrum from the commercial system. This confirms the spectral accuracy of the system described herein in capturing the chemical signature of PS beads.
[0424] Collagen fibers are of great interest in assessing renal fibrosis and disease progression such as lupus nephritis (LN). The MIP-OCT system was utilized in biomedical imaging by detecting collagen in 5 pm thickness mouse kidney tissue sample. The effectiveness of the system was demonstrated by delivering comparable chemical contrast to a benchtop system. In the Figure 3, the results show a clear differentiation between collagenous and non-collagenous tissue. The column I are Masson’s tri chrome images and the collagen is marked as green and dark blue. The pure collagen is stained as green, the blue stain indicates the mix of collagen and nuclear. The brightfield images offer an overall view of the kidney’s histological structure. The column II presents the en face OCT images, revealing detailed structural information like glomerulus, but resolution is not enough to recognize the uriniferous tubules. The column III presents the extracted MIP images from OCT at collagen absorption peak 1240 cm’1. The images highlighting the collagen distributions which align with the Masson’s tri chrome stain (Column I)and benchtop MIP images (Column IV). But the spatial resolution of MIP images is lower than OCT.
[0425] Methods
[0426] Experimental Setup. The MIP OCT spectroscopic system schematic is presented in Figure 4A. The Mid-Infrared (MIR) source is a pulsed quantum cascade laser (QCL) from Daylight Solutions. The QCL has a pulse rate of 100kHz with a 5% pulse width. An arbitrary waveform generator was used to electronically modulate the QCL at 1kHz with 30% pulse duty cycle. Here, a lower modulation frequency was selected to gain a higher signal-to-noise ratio. The MIR beam was aligned and focused on the sample by the off-axis parabolic mirror (OAP) (Thorlabs, 0.5 inch diameter, 15 mm focal length). The use of OAP ensures that the MIR beams are focused on the same spot without introducing any chromatic aberration. The fine alignment of the OAP with respect to the incoming beam was performed to reduce the unwanted aberrations introduced by the OAP. The modulated MIR light is then absorbed by the sample transformed into heat, which creates a periodic local temperature variation. The temporary increase in temperature causes the thermal expansion and index of refraction. Both effects result in a local change in optical path length around the focal point. Repeated OCT line scans (A-scan) are taken over multiple MIR heating and cooling cycles for each sample position.
[0427] The near-infrared (NIR) probe beam was sourced from a high-speed swept-source OCT engine (Axsun-Excelitas Technologies, Inc). The central wavelength is 1310 nm, wavelength tuning range is 136.17 nm, output power is 28.3 mW, sweep rate 100.16 kHz. The theoretical axial resolution is 6 pm. A single mode fiber (SMF) circulator (Thorlabs), connected with a NIR collimator, was used to direct the swept-source laser to a short-pass dichroic (Thorlabs), an objective (Thorlabs, LSM54-1310) was used to focus NIR on the same sample area as the MIR. The back-reflected components of the reference and sample light were coupled back to the circulator and measured by a photo-diode on the OCT engine. The NIR beam co-aligned with the visible beam at the short-pass dichroic. The visible 639 nm light-emitting diode (LED) (Thorlabs) provides Kohler illumination on the sample. A CMOS camera (Baysler) captures the bright-field image for visualization and localizing area of interest (ROI). The common-path OCT configuration is shown in Figure 4(B). The optical surface of the reference plate proximal to the sample was used as the reference. Here, a CaF2 window (Crystran, 13 mm diameter, 1 mm thickness) was used as the reference plate since it has high MIR transmission. The reference surface of reference plate and sample shared a common optical path, minimizing the dispersion induced by difference refractive index of optical path, reducing phase instability.Data processing. Figure 4(C) shows the diagram of extracting photothermal signal from OCT raw signal. Raw signals are recorded over MIP modulation cycles (Hot and Cold). Each raw signal received by the photodetector consists of superimposed interferogram: the interference between light reflection of top and bottom surfaces of the reference plate and the interference between two surfaces and scattered light of sample in different photothermal cycles. The raw signals are processed through the Fourier transform (FT) to extract depth-resolved information. The FT helps separate the real and imaginary parts of the signal and the phase is computed. The result of this decomposition shows distinct peaks corresponding to the hot and cold signal. By plotting the phase changes over the MIR modulation cycles, the photothermal information is extracted.
[0428] Sample Preparation. The system described herein was tested on a variety of sample types. First, images of a custom USAF target were obtained. The target is a positive target made of PMMA on CaF2 substrate. It should be noted that the smaller the USAF bars are, the more fragile it is. As a result, some bars were broken in the process of transportation. The Arden Photonics reference target APL-OPOl (Arden Photonics Ltd., Solihull, United Kingdom) was used for characterizing the OCT imaging performance of the system Polystyrene (PST) beads on CaF2 slides were also used for system characterization. The PST beads are 25 pm and 40 pm in diameter respectively. The beads were diluted and washed with 70% ethanol.
[0429] Formalin-fixed paraffin-embedded mouse kidney biopsy samples were obtained from the Center for Nuclear Receptors and Cell signaling, University of Houston. The sample was cut into two consecutive 5 pm thick sections. The first section was placed on a glass slides and the adjacent section was placed on a CaF2 slides. The samples were then de-paraffinized using xylene and ethanol. The section on the glass was stained with Masson’s trichrome and imaged with a bright-field microscope. The section on the CaF2 was for imaging on the system described herein.
[0430] A healthy adult rat brain (18 month, male, wild type) was obtained from the Biomedical Optics Laboratory (Department of Biomedical Engineering, University of Houston). All animal experiments were approved by the animal ethics committee of the University of Houston.
[0431] Following fixation, the brain tissue was washed four times with phosphate-buffered saline (PBS) to remove any residual. The brain was immediately immersed in 4% paraformaldehyde (PF A) at 4°C for 24 hours to ensure proper fixation and preservation of tissue architecture. Myelin sheath integrity in postmortem brain tissue is not affected by proper fixation (de Campos et al., 1980). After fixation. Acrylic Brain Matrices (Kent Scientific, Coronal Slices, 1 mm) was used for slicing 1 mm tissue block. After sectioning, the tissue block was placed with PBS in a 3D-printchamber, an O-ring and CaF2 circular window (Crystran, 25 mm diameter, 1 mm thickness) were used for sealing the chamber for the sample preservation during imaging.
[0432] Throughout this example, the commercial system (MIRAGE) provided by Photothermal Spectroscopy Corp was used to obtain benchtop MIP images and the bright-field image were obtained with a Nikon Ti2 inverted microscope.
[0433] Conclusion. A label-free mid-infrared photothermal optical coherence tomography (MIP-OCT) system that integrates high-resolution structural imaging with biochemical contrast was demonstrated. Comprehensive testing with both custom and commercially available targets validated the system’s spatial fidelity and lateral resolution, which align with theoretical expectations. The results confirm that the MIP subsystem achieves slightly finer lateral resolution compared to the OCT subsystem, while maintaining robust depth-resolved imaging capabilities.
[0434] In biomedical imaging applications, the system successfully identified collagen distributions in mouse kidney tissue with chemical contrast comparable to benchtop systems, while retaining structural details through OCT imaging. This demonstrates the potential of MIP-OCT for assessing tissue-specific biomarkers, such as collagen in renal fibrosis. Furthermore, spectral validation using polystyrene beads highlighted the system’s accuracy in capturing chemical signatures, with spectral results closely matching those from commercial systems.
[0435] The MIP-OCT system represents a significant advancement by combining the versatility of OCT with the biochemical contrast of mid-infrared photothermal detection. This innovation enables high-resolution imaging of structural and chemical properties in a label-free manner, paving the way for impactful applications in clinical diagnostics and basic biological research. Its compact and integrated design further enhances its potential for translational and point-of-care use.
[0436] References
[0437] [1] Huang D et al. Optical coherence tomography. Science 254(5035), 1178-1181 (1991) [2] Dubois A et al. High-resolution full-field optical coherence tomography with a linnik microscope. Applied optics 1(4), 805-812 (2002)
[0438] [3] Dubois A et al. Ultrahigh-resolution full-field optical coherence tomography. Applied optics 43(14), 2874-2883 (2004)
[0439] [4] Drexler W et al. Ultrahigh-resolution ophthalmic optical coherence tomography. Nature medicine 7(4), 502-507 (2001)
[0440] [5] Aumann S et al. Optical coherence tomography (oct): principle and technical realization. High resolution imaging in microscopy and ophthalmology: new frontiers inbiomedical optics, 59-85 (2019)
[0441] [6] Lains I et al. Retinal applications of swept source optical coherence tomography (oct) and optical coherence tomography angiography (octa). Progress in retinal and eye research 84, 100951 (2021)
[0442] [7] Lim L et al. Comparison of spectral domain and swept-source optical coherence tomography in pathological myopia. Eye 28(4), 488-491 (2014)
[0443] [8] Wang S et al. Label-free optical imaging in developmental biology. Biomedical Optics Express 11(4), 2017-2040 (2020)
[0444] [9] Cheng JX et al. Vibrational spectroscopic imaging of living systems: An emerging platform for biology and medicine. Science 350(6264), 8870 (2015)
[0445]
[0010] Aghigh A et al. Second harmonic generation microscopy: a powerful tool for bioimaging. Biophysical Reviews 15(1), 43-70 (2023)
[0446]
[0011] Jones RR et al. Raman techniques: fundamentals and frontiers. Nanoscale research letters 14, 1-34 (2019)
[0447]
[0012] Bhargava R. Digital histopathology by infrared spectroscopic imaging. Annual Review of Analytical Chemistry 16(1), 205-230 (2023)
[0448]
[0013] Chen J et al. High-performance second-harmonic-generation (shg) materials: new developments and new strategies. Accounts of Chemical Research 54(12), 2775-2783 (2021)
[0449]
[0014] Hu F et al. Biological imaging of chemical bonds by stimulated raman scattering microscopy. Nature methods 16(9), 830-842 (2019)
[0450]
[0015] Freudiger CW et al. Label-free biomedical imaging with high sensitivity by stimulated raman scattering microscopy. Science 322(5909), 1857-1861 (2008)
[0451]
[0016] Griffiths PR. Fourier transform infrared spectrometry. Science 222(4621), 297-302 (1983)
[0452]
[0017] Baker MJ et al. Using fourier transform ir spectroscopy to analyze biological materials. Nature protocols 9(8), 1771-1791 (2014)
[0453]
[0018] Fernandez DC et al. Infrared spectroscopic imaging for histopathologic recognition. Nature biotechnology 23(4), 469-474 (2005)
[0454]
[0019] Zhang D et al. Depth-resolved mid-infrared photothermal imaging of living cells and organisms with submicrometer spatial resolution. Science advances 2(9), 1600521 (2016)
[0455]
[0020] Shi J et al. High-resolution, high-contrast mid-infrared imaging of fresh biological samples with ultraviolet-localized photoacoustic microscopy. Nature photonics 13(9), 609-615 (2019)
[0456]
[0021] Pleitez MA et al. Label-free metabolic imaging by mid-infrared optoacousticmicroscopy in living cells. Nature biotechnology 38(3), 293-296 (2020)
[0457]
[0022] Tamamitsu M et al. Label-free biochemical quantitative phase imaging with midinfrared photothermal effect. Optica 7(4), 359-366 (2020)
[0458]
[0023] Zhao J et al. Bond-selective intensity diffraction tomography. Nature Communications 13(1), 7767 (2022)
[0459]
[0024] Wang S et al. Optical coherence elastography for tissue characterization: a review. Journal of biophotonics 8(4), 279-302 (2015)
[0460]
[0025] Larin KV et al. Optical coherence elastography-oct at work in tissue biomechanics. Biomedical optics express 8(2), 1172-1202 (2017)
[0461]
[0026] Kennedy BF et al. A review of optical coherence elastography: fundamentals, techniques and prospects. IEEE Journal of Selected Topics in Quantum Electronics 20(2), 272-288 (2013)
[0462]
[0027] Plekhanov AA et al. Histological validation of in vivo assessment of cancer tissue inhomogeneity and automated morphological segmentation enabled by optical coherence elastography. Scientific reports 10(1), 11781 (2020)
[0463]
[0028] Gambichler T et al. Applications of optical coherence tomography in dermatology. Journal of dermatological science 40(2), 85-94 (2005)
[0464]
[0029] Chen Z et al. Noninvasive imaging of in vivo blood flow velocity using optical doppler tomography. Optics letters 22(14), 1119-1121 (1997)
[0465]
[0030] Izatt JA et al. In vivo bidirectional color doppler flow imaging of picoliter blood volumes using optical coherence tomography. Optics letters 22(18), 1439-1441 (1997)
[0466]
[0031] Leitgeb RA et al. Doppler optical coherence tomography. Progress in retinal and eye research 41, 26-43 (2014)
[0467]
[0032] Yazdanfar S et al. In vivo imaging of human retinal flow dynamics by color doppler optical coherence tomography. Archives of ophthalmology 121(2), 235-239 (2003)
[0468]
[0033] Zhao Y et al. Phase-resolved optical coherence tomography and optical doppler tomography for imaging blood flow in human skin with fast scanning speed and high velocity sensitivity. Optics letters 25(2), 114-116 (2000)
[0469]
[0034] Morgner U et al. Spectroscopic optical coherence tomography. Optics letters 25(2), 111-113 (2000)
[0470]
[0035] Adler DC et al. Photothermal detection of gold nanoparticles using phase-sensitive optical coherence tomography. Optics express 16(7), 4376-4393 (2008)
[0471]
[0036] Tucker-Schwartz J et al. In vivo photothermal optical coherence tomography of gold nanorod contrast agents. Biomedical optics express 3(11), 2881-2895 (2012)
[0037] Makita S et al. In vivo photothermal optical coherence tomography for non-invasive imaging of endogenous absorption agents. Biomedical optics express 6(5), 1707-1725 (2015)
[0472]
[0038] Zong H et al. Bond-selective full-field optical coherence tomography. Optics Express 31(25), 41202-41218 (2023)
[0473] Example 3- Compact, Miniaturized, Handheld, Portable System for Label-Free, Chemically Sensitive Imaging
[0474] Photothermal mid-infrared spectroscopic imaging (MIRSI) is an emerging, label-free technology that can identify the molecular composition and structure of heterogeneous samples, such as tissue and polymers, on a microscopic scale. However, existing systems are bulky and limited to large benchtop setups. In this work, the first portable, handheld photothermal MIRSI system is introduced, which can potentially translate this innovative technology into clinical and field settings. A flexible fiber optic probe configuration that supports multiple scanning methods, depending on the application, has been developed. Additionally, the capabilities of this technology are demonstrated on polystyrene, Poly(methyl methacrylate) (PMMA), ovarian, cervical, kidney, and bone marrow tissue samples, illustrating its versatility.
[0475] Current systems are large and confined to bulky benchtop setups. Herein, a handheld, portable, miniaturized system is developed. The handheld component is 8 inch x 8 inch, whereas benchtop systems are typically 3 ft x 4 ft or larger. A versatile fiber optic probe configuration was designed that accommodates multiple scanning methods that can be tailored to specific applications. This innovation paves the way for a new generation of label-free imaging technologies, such as photothermal mid-infrared spectroscopic imaging, to be implemented in clinical environments, point-of-care settings, and field operations.
[0476] This allows the clinical translation and field use of the label-free imaging technology that is being deployed. A handheld, portable system configuration has been developed that makes the technology easy to use. The benchtop system is available from commercial vendors. The new technology herein is an improvement on those systems.
[0477] Current systems are large and confined to bulky benchtop setups. Developed herein is a handheld, portable, miniaturized system. The handheld component is 8 inch x 8 inch, whereas benchtop systems are typically 3 ft x 4 ft or larger. This makes it easy to use and will allow use in a wider variety of locations including in hospitals, clinical settings and field use in plastics and materials industries.
[0478] The miniaturization will enable use across a broader range of environments, including hospitals, clinical settings, and field applications in the plastics, materials, and oil industries.Example 4 - Development of a Compact Fiber-Optic System for Label-Free, Chemically Sensitive Imaging
[0479] Abstract. Photothermal mid-infrared spectroscopic imaging (MIRSI) is an emerging, label-free technology that can identify the molecular composition and structure of heterogeneous samples, such as tissue and polymers, on a microscopic scale. However, existing systems are bulky and limited to large benchtop setups. Herein, the first portable, handheld photothermal MIRSI system is introduced, which can potentially translate this innovative technology into clinical and field settings. A flexible fiber optic probe configuration was developed that supports multiple scanning methods, depending on the application. Additionally, the capabilities of this technology were demonstrated on polystyrene, Poly(methyl methacrylate) (PMMA), ovarian, cervical, kidney, and bone marrow tissue samples, illustrating its versatility.
[0480] Introduction. Endoscopy and microscopy are critical diagnostic tools in the wide array of diseases [A4-A20], However, they currently lack biochemical specificity without the use of external contrast agents. This work presents a label-free, biochemically specific, miniaturized, fiber-optic imaging technology capable of sub-cellular resolution imaging. It introduces a new class of biomedical imaging devices that perform label -free chemical imaging in a portable, handheld form factor, thus opening the door to point-of-care applications.
[0481] Endomicroscopy is a minimally invasive diagnostic tool used for various diseases ranging from gastrointestinal and pulmonary diseases to identification of gynecologic cancers. It reduces the need for painful and costly procedures and speeds up diagnoses [A4-A20], Endomicroscopic imaging methods are an attractive biomedical tool for diagnosis in a large variety of diseases [A4-A20] at the point of care due to their minimally invasive nature. They help minimize the need for expensive and painful invasive procedures and accelerate diagnosis. These methods coupled with data analysis tools can provide quantitative insight into the disease. Current label-free endomicroscopy technologies such as optical coherence tomography [Al, A2] and confocal laser endomicroscopy [A3] provide good morphological contrast, but cannot provide biochemical and functional contrast. Several approaches to deliver such contrast have been proposed. However, it requires external contrast agents which are limited in the variety of biomolecular constituents they can recognize. Contrast agents that go into the human body are challenging to develop as they impose stringent safety and efficacy criteria that are not easily met. Label-free methods with biochemical specificity provide an excellent alternative. Researchers have invested extensive effort in developing label-free, biochemically sensitive imaging methods. Raman Spectroscopy [A21], Infrared Imaging [A22], Second Harmonic Generation (SHG) [A23] are some notable label-free methods. These methodscan provide chemical differentiation without needing external chemical contrast. However, these methods have limitations in speed, signal-to-noise ratio (SNR), and contrast.
[0482] SHG is a non-linear imaging method that provides sharp contrast. However, it requires the sample under investigation to be non-centrosymmetric [A24] to provide contrast without an added external agent. As a result, this method has only been successful in imaging collagenous tissue without external contrast agents [A26], Besides, it requires a high numerical aperture objective to deliver concentrated laser energy to the sample [A25],
[0483] Raman Spectroscopy probes the molecular vibrations and rotational transitions of the sample through inelastic scattering. This method can provide good chemical sensitivity without external agents in the biological fingerprint region. But Spontaneous Raman Scattering suffers from low signal levels requiring long integration time. Coherent Raman methods [A28, A29] were developed to provide orders of magnitude higher signal levels compared to Spontaneous Raman Scattering processes [A27], Still, the signal level is limited by the absorption crosssection of Raman methods.
[0484] In contrast, mid-infrared provides eight orders of magnitude higher absorption crosssection and correspondingly higher sensitivity and speed relative to Raman methods [A37], Thus mid-infrared imaging methods such as Discrete Frequency Infrared Imaging [A30, A31] and Fourier Transform Infrared Spectroscopy [A32-A35] provides higher signal-to-noise ratio images compared to Raman methods. However, their spatial resolution is limited by the diffraction limit of the large IR wavelengths.
[0485] A modality of infrared imaging that addresses some of the shortcomings of these imaging modalities is Mid-Infrared Spectroscopic Imaging (MIRSI) [A36] . In this method, a pump beam excites the vibrational modes of the sample. When the sample returns to an equilibrium state through non-radiative relaxation it causes a local temperature change in the sample. This causes an expansion and a change in the refractive index. This change is then detected by a probe beam. Different system modalities have been proposed based on whether the refractive index change or the expansion is measured [A38-A44], Regardless of the probing method used, the wavelength of light for the probe beam is in the visible range. MIRSI thus provides a diffraction limit in the visible and absorption cross-section in the Mid-Infrared. This method has been applied successfully to image different bio-markers in various samples of interest [A45-A54], While this imaging modality has seen a lot of success in the laboratory environment, some challenges need to be addressed for a successful clinical translation. Since the system uses pump light in the midinfrared and probe light in the visible, it usually requires two separate paths for the pump and the probe in the counter propagation scheme or requires the use of bulky focusing optics in theco-propagation scheme [A37], These factors culminate in a final system that is large and can only be used in benchtop applications.
[0486] Herein, these design challenges are overcome and the first handheld, flexible, fiber-optic laser-scanning MIRSI-probe and a compact MIRSI system is presented that facilitates clinical translation of this technology. This miniaturized MIRSI technology opens the door to a new class of endoscopic MIRSI systems, which can deliver label-free, biochemically specific imaging. All prior MIRSI instruments had a large footprint (> 10 sq. ft.) typically mounted on an optical table. Herein, a compact MIRSI system (< 2 sq. ft.) and a miniaturized fiber-optic probe (8 inches x 8 inches) are proposed that makes it possible to transfer this technology to biomedical and clinical settings with ease, overcoming several challenges with translation to point-of-care clinical applications. This compactness was achieved through several design choices such as the use of fiber-coupled mid-infrared pump light and reflective optical components which are common to both the pump and the probe light. Several biomedical applications of this technology are demonstrated and the advantages of its flexibility, robustness, and ease of use relative to current benchtop MIRSI technologies is presented. In the following section, the system is applied to different use cases and the results are compared with an existing commercial benchtop system. In the methods section, the design of the system is elaborated on and the specifics of the data acquisition are described.
[0487] Results and Discussion. The proposed miniaturized MIRSI technology has comparable performance to the state-of-the-art benchtop system while being compact and flexible. The system performance is validated by comparing both spatial and spectral data to state-of-the-art benchtop MIRSI technology. The results of this comparison are shown in the Figure 6. As a measure of the performance of the system described herein, the mean-square-error (MSE) between the images from the system described herein and those obtained from the benchtop system is estimated. The MSE for the figure with groups 4 and 5 is 0.038, and 0.041 for groups 6 and 7. The low MSE values show that the performance of the system described herein is comparable to that of the benchtop system but with the added benefit of being very compact.
[0488] The spatial and spectral fidelity of the compact imaging system was examined by imaging polymer beads. The results are shown in the Figure 7. Figure 7(D), Figure 7(E), and Figure 7(F) show the beads in different imaging conditions. Figure 7(H) shows that the spectrum from the system described herein matches the spectrum collected from the benchtop system except near the start. The reason is that the system described herein uses a quantum cascade laser (QCL) that has a chip transition at 1143 cm’1. As a result, the power is low in that region and the normalized spectrum near the start is not reliable. Figure 7(1) and Figure 7(J) give a quantitativemeasure of the system resolution. The line profile of the central bead in Figure 7(1) is plotted in Figure 7(J). The dots in Figure 7(J) represent the raw data. A double Gaussian with an RMSE of 0.022 was fitted to the data and the FWHM was estimated to be 3.45 pm. This was assumed to be the FWHM of the point-spread function (PSF). Thus, the resolution of the system described herein is reported to be 3.45 pm. This comes close to the theoretical resolution limit of 3.13 pm. It should be noted that in the Figure 7(K) the bead seems to be larger along one dimension than the other. This image was collected using the benchtop system and the aberration can be attributed to a misalignment in the system and is not an inherent drawback of the system.
[0489] For successful clinical translation of an imaging system, it should be compact while delivering comparable performance to a benchtop system in tissue imaging. Therefore, the performance of the compact system described herein in tissue imaging is shown and the results are compared to the benchtop system.
[0490] Collagen fibers were chosen as the target bio-marker. Collagen fibers are of great interest in cancer diagnosis. Cancerous tissues show an increased collagen expression in its microenvironment [A55] . Collagen fiber identification and quantization can give valuable insight into the cancer progression in the patient.
[0491] Cervical and ovarian biopsy tissue were imaged with the system described herein (Figure 8). The images show a clear differentiation between collagenous and non-collagenous tissue (Figure 8). As is evident from the H&E images in Figure 8, there is a clear differentiation between the stromal and epithelial tissue. Stromal tissue is mostly made up of connective tissue of which collagen fibers are fundamental blocks. Imaging the tissue at the collagen absorption peak shows a clear contrast between the stromal and epithelial tissue. This makes the system described herein a viable option for clinical translation.
[0492] The system described herein was also used to image a bone tissue from a patient with myelofibrosis. The corresponding tissue images are illustrated in the Figure 9. Myelofibrosis is a type of bone cancer where bone marrow gets replaced by fibrous scar tissue. This can be diagnosed from the excess buildup of collagen fibers in the tissue. From the Masson’s tri chrome stained image in the Figure 9(C), a buildup of blue collagen fibers surrounding the blood vessel can be seen. When imaged at the collagen absorption band at 1240 cm’1, the region surrounding the blood vessels becomes brighter than the other regions, which points to the presence of collagen fibers in that region. The band images at the collagen peak can be used by predictive models downstream to provide a quantitative estimation of the collagen fibrosis as opposed to the standard qualitative estimation from Masson’s tri chrome stained images. This can lead to digitalization and standardization of the current grading system for myelofibrosis, and thus allowfor early identification of the development of myelofibrosis in patients with newly-diagnosed myeloproliferative neoplasms, as well as those who do not respond to standard-of-care therapy and need to be transferred to alternative therapies.
[0493] Finally, results of the rotational -translational scanning are shown in Figure 10. The images show similar performance to the images from scanning by moving the sample. The smaller field of view of the images is noted. As the OAP scans across the sample, the focus of the beam moves away from the sample. Thus the field of view is limited by the depth of focus. A larger field of view can be achieved using a longer focal length OAP, trading off the resolution.
[0494] Methods
[0495] Experimental Setup. The miniaturized system schematic is shown in Figure 11. The Mid-Infrared (MIR) source is a Pulsed QCL from Daylight Solutions. The QCL has a pulse rate of 100 kHz with a 5% pulse width. Even though the detection electronics are capable of demodulating the MIRSI signal at this frequency, a lower modulation frequency was selected to gain a higher signal-to-noise ratio. An arbitrary waveform generator was used to electronically modulate the QCL at 1 KHz with 50% pulse width. The light from the QCL was coupled into a MIR chalcogenide single-mode fiber (IRFlex IRF-Se-12) through an aspheric condenser. The fiber is truly single mode for wavelengths larger than 7.4 pm. The numerical aperture of the aspheric condenser was selected such that it achieves optimal mode matching with the fiber. The condenser was anti-reflective (AR) coated with transmission in the range of 8 - 12 pm. The fiber single-mode operation coupled with the transmission range of the aspheric condenser limited the effective spectral bandwidth. The MIR fiber delivers light into the system through the reflective collimator. The use of the reflective collimator avoids introducing any chromatic divergence from the large bandwidth of MIR light. A 639 nm diode laser was used as the probe beam. One port of a 2 x 2 fiber coupler delivers the light into the system through the fixed focus collimator. The MIR beam co-aligns with the visible beam at the short-pass dichroic. The Off-Axis Parabolic Mirror (OAP) focuses both beams on the sample. The use of OAP ensures that both beams are focused on the same spot without introducing any chromatic aberration. It should be noted that OAPs are generally not used in imaging applications as they introduce unwanted aberrations in the image [A56] . But, herein these aberrations were able to be reduced through fine alignment of the OAP with respect to the incoming beam. The use of OAP as the imaging optics and the fiber coupled mid-infrared light delivery results in a compact system that was not possible with traditional reflective objectives and free space light delivery. The backscattered light is collected by the visible collimator and couples into the photodiode through another port of the fiber coupler. The photodiode signal is amplified by a transimpedance amplifier. Thesignal is DC coupled into a multi-instrument data acquisition and processing platform. Here, the raw signal is lock-in-amplified digitally at the QCL modulation rate and passed to one channel of a digitizer Parallelly, the raw signal is low pass filtered at 1 kHz cutoff frequency. The filtered signal is connected to another channel of the digitizer and acts as the confocal scanning image signal while the lock-in-amplified signal is the desired MIRSI signal.
[0496] Sample Preparation and Data Acquisition. The system described herein was tested on a variety of sample types. First, images of a custom USAF target were obtained. The target is a positive target made of PMMA on a CaF2 substrate. It should be noted that the smaller the USAF bars are the more fragile they are. As a result, some bars were broken in the process of transportation.
[0497] PMMA and Polystyrene (PST) beads were also placed on CaF2 slides for characterizing the system. The PMMA and PST beads are 5 pm and 2 pm in size, respectively. The beads were diluted and washed with 70% ethanol.
[0498] Human cervical and ovarian biopsy tissue micro-array were obtained from Biomax US, Rockville, MD. The parraffin-embedded tissue were deparaffinized prior to MIRSI imaging. CaF2 was used as the substrate for the tissue that underwent MIRSI imaging. The corresponding adjacent sections were stained with H&E and were used for bight field imaging.
[0499] Formalin-fixed paraffin-embedded human clinical bone biopsy samples were also obtained and cut 3 pm thick sections. One section was placed on a CaF2 substrate and the adjacent section was placed on glass slides. The samples were then deparaffinized. The section of CaF2 was used for photothermal imaging while the adjacent section on glass was stained with Masson’s tri chrome and imaged with a light field microscope.
[0500] A 7 pm paraffin-embedded mouse kidney tissue was obtained and placed on a silicon window. The tissue was then deparaffinized in xylene and ethanol. This tissue section was used for rotational scanning imaging.
[0501] A commercial system by Photothermal Spectroscopy Corp was used throughout to obtain reference MIRSI images and the bright-field images were obtained with a Nikon Ti2 inverted microscope.
[0502] Conclusion. MIRSI imaging is an emerging spectroscopic method with vast applications in biomedicine as a label-free imaging modality. Here, a new MIRSI system was developed that is more compact and flexible compared to large benchtop setups. The performance of the system was validated with standard test samples and some clinical applications of the system were shown. A mechanism for two dimensional scanning was implemented that is fully integrated in the system itself. The design of this new system opens up the possibility of implementing aendoscopic probe for in-vivo label -free imaging of biological tissue.
[0503] It is noted that the system had a limited spectral bandwidth as a result of the single mode operation cut-off of the mid-infrared fiber and the corresponding coupling optics. A separate system can designed that utilizes a different spectral region with the corresponding fiber and coupling optics based on the same design principle as the one described herein.
[0504] It is also noted that the maximum mid-infrared power the system had available for imaging was ~ 3.5 mW at the peak wavenumber of the QCL chip. This is much less than the tens of milliwatts of mid-infrared power available to the benchtop systems. As a result the system needed to integrate for longer time (~ 30 ms) at each pixel to collect high SNR images. This low available power was a result of the coupling inefficiency of the midinfrared fiber and a slight mode mismatch between the off the shelf coupling optics and the fiber. Much high power coupling is possible with custom optics that completely matches the modal diameter of the fiber face. This higher mid-infrared power when delivered into the system can provide much faster acquisition time.
[0505] References
[0506] [Al] Optical Coherence Tomography: Technology and Applications. (Springer International Publishing, Cham, 2015). doi: 10.1007 / 978-3-319-06419-2.
[0507] [A2] Gora MJ et al. Endoscopic optical coherence tomography: technologies and clinical applications [Invited], Biomed. Opt. Express 8, 2405 (2017).
[0508] [A3] Jabbour JM et al. Confocal Endomicroscopy: Instrumentation and Medical Applications. Ann Biomed Eng 40, 378-397 (2012).
[0509] [A4] Metcalfe C et al. A systematic review of remote ontological assessment using video-otoscopy over the past 10 years: reliability and applications. Eur Arch Otorhinolaryngol 278, 4733-4741 (2021).
[0510] [A5] East J et al. Advanced endoscopic imaging: European Society of Gastrointestinal Endoscopy (ESGE) Technology Review. Endoscopy 48, 1029-1045 (2016).
[0511] [A6] Shen YC et al. Advances in Diagnostic Bronchoscopy. Diagnostics 11, 1984 (2021).
[0512] [A7] Tang Y et al. Advances in optical gastrointestinal endoscopy: a technical review. Molecular Oncology 15, 2580-2599 (2021).
[0513] [A8] Friedt M et al. An update on pediatric endoscopy. European Journal of Medical Research 18, 24 (2013).
[0514] [A9] Coda S et al. Biophotonic endoscopy: a review of clinical research techniques for optical imaging and sensing of early gastrointestinal cancer. Endosc Int Open 03, E380-E392(2015).
[0515] [A10] Mitchell MF et al. Colposcopy For The Diagnosis of Squamous Intraepithelial Lesions: A Meta- Analysis. Obstetrics & Gynecology 91, 626-631 (1998).
[0516] [All] Pilonis ND et al. Confocal laser endomicroscopy in gastro-intestinal endoscopy: technical aspects and clinical applications. Transl Gastroenterol Hepatol 7, 7 (2022).
[0517] [A12] Abad MRA et al. Endocytoscopy: technology and clinical application in upper gastrointestinal tract. Transl Gastroenterol Hepatol 5, 28 (2020).
[0518] [A13] Pfau PR et al. Endoscopic diagnostics. Gastroenterology 120, 763-781 (2001). [A14] Hatlebakk JG. Endoscopy in gastrooesophageal reflux disease. Best Practice & Research Clinical Gastroenterology 24, 775-786 (2010).
[0519] [Al 5] Kraus O et al. New Technology for the Diagnosis of Otitis Media. Otolaryngology Head and Neck Surgery (2018).
[0520] [A16] He Z et al. Novel endoscopic optical diagnostic technologies in medical trial research: recent advancements and future prospects. BioMedical Engineering OnLine 20, 5 (2021).
[0521] [A17] Kim JA et al. Optical spectroscopy for in vivo medical diagnosis — a review of the state of the art and future perspectives. Prog. Biomed. Eng. 2, 042001 (2020).
[0522] [Al 8] Brown BH et al. The diagnostic accuracy of colposcopy - A review of research methodology and impact on the outcomes of quality assurance. European Journal of Obstetrics & Gynecology and Reproductive Biology 240, 182-186 (2019).
[0523] [A19] Gulati S et al. The future of endoscopy: Advances in endoscopic image innovations. Digestive Endoscopy 32, 512-522 (2020).
[0524] [A20] Olaniyan OB. Validity of Colposcopy in the Diagnosis of Early Cervical Neoplasia: A Review. African Journal of Reproductive Health / La Revue Africaine de la Sant'e Reproductive 6, 59-69 (2002).
[0525] [A21] Jones RR et al. Raman Techniques: Fundamentals and Frontiers. Nanoscale Res Lett 14, 231 (2019).
[0526] [A22] Bhargava R. Digital Histopathology by Infrared Spectroscopic Imaging. Annual Review of Analytical Chemistry 16, 205-230 (2023).
[0527] [A23] Aghigh A et al. Second harmonic generation microscopy: a powerful tool for bioimaging. Biophys Rev 15, 43-70 (2023).
[0528] [A24] Nonlinear Optics. (Elsevier, 2020). doi:10.1016 / C2015-0-05510-l.
[0529] [A25] Campagnola PJ et al. Second-harmonic imaging microscopy for visualizing biomolecular arrays in cells, tissues and organisms. Nat Biotechnol 21, 1356-1360 (2003).[A26] Chen X et al. Second harmonic generation microscopy for quantitative analysis of collagen fibrillar structure. Nat Protoc 7, 654-669 (2012).
[0530] [A27] Pestov D et al. Coherent versus incoherent Raman scattering: molecular coherence excitation and measurement. Opt. Lett. 32, 1725 (2007).
[0531] [A28] Camp Jr, CH et al. Chemically sensitive bioimaging with coherent Raman scattering. Nature Photonics 9, 295-305 (2015).
[0532] [A29] Cheng JX et al. Vibrational spectroscopic imaging of living systems: An emerging platform for biology and medicine. Science 350, aaa8870 (2015).
[0533] [A30] Kole MR et al. Discrete Frequency Infrared Microspectroscopy and Imaging with a Tunable Quantum Cascade Laser. Anal. Chem. 84, 10366-10372 (2012).
[0534] [A31] Yeh K et al. Fast Infrared Chemical Imaging with a Quantum Cascade Laser. Anal. Chem. 87, 485-493 (2015).
[0535] [A32] Griffiths PR et al. Fourier Transform Infrared Spectrometry. (Wiley, 2007).
[0536] *General reference for FTIR
[0537] [A33] Baker MJ et al. Using Fourier transform IR spectroscopy to analyze biological materials. Nat Protoc 9, 1771-1791 (2014).
[0538] [A34] Lewis E et al. Fourier Transform Spectroscopic Imaging Using an Infrared Focal-Plane Array Detector. Anal. Chem. 67, 3377-3381 (1995).
[0539] [A35] Fernandez DC et al. Infrared spectroscopic imaging for histopathologic recognition. Nat Biotechnol 23, 469-474 (2005).
[0540] [A36] Zhang D et al. Depth-resolved mid-infrared photothermal imaging of living cells and organisms with submicrometer spatial resolution. Science Advances 2, el 600521 (2016).
[0541] [A37] Bai Y et al. Bond-selective imaging by optically sensing the mid-infrared photothermal effect. Sci. Adv 7, 1559-1573 (2021).
[0542] [A38] Schnell M et al. All-digital histopathology by infrared-optical hybrid microscopy. Proc. Natl. Acad. Sci. U.S.A. 117, 3388-3396 (2020).
[0543] [A39] Bai Y et al. Ultrafast chemical imaging by widefield photothermal sensing of infrared absorption. Science Advances 5, eaav7127 (2019).
[0544] [A40] Zhang D et al. Bond-selective transient phase imaging via sensing of the infrared photothermal effect. Light Sci Appl 8, 116 (2019).
[0545] [A41] Yin J et al. Video-rate mid-infrared photothermal imaging by single-pulse photothermal detection per pixel. Science Advances 9, eadg8814 (2023).
[0546] [A42] Ishigane G et al. Label -free mid-infrared photothermal live-cell imaging beyond video rate. Light Sci Appl 12, 174 (2023).[A43] Li M et al. Fluorescence-Detected Mid-Infrared Photothermal Microscopy. J. Am. Chem. Soc. 143, 10809-10815 (2021).
[0547] [A44] Zhang Y et al. Fluorescence-Detected Mid-Infrared Photothermal Microscopy. J. Am. Chem. Soc. 143, 11490-11499 (2021).
[0548] [A45] Kato R et al. High-sensitivity hyperspectral vibrational imaging of heart tissues by midinfrared photothermal microscopy. ANAL. SCI. 38, 1497-1503 (2022).
[0549] [A46] Huang J et al. In situ molecular mapping of human testicular tissues by midinfrared photothermal imaging, in Advanced Optical Imaging Technologies VI vol. 1276695-101 (SPIE, 2023).
[0550] [A47] Tamamitsu M et al. Label-free biochemical quantitative phase imaging with midinfrared photothermal effect. Optica, OPTICA 7, 359-366 (2020).
[0551] [A48] GvazavaN et al. Label-Free High-Resolution Photothermal Optical Infrared Spectroscopy for Spatiotemporal Chemical Analysis in Fresh, Hydrated Living Tissues and Embryos. J. Am. Chem. Soc. 145, 24796-24808 (2023).
[0552] [A49] Gajjela CC et al. Leveraging mid-infrared spectroscopic imaging and deep learning fortissue subtype classification in ovarian cancer. Analyst 148, 2699-2708 (2023).
[0553] [A50] He H et al. Mapping enzyme activity in living systems by real-time mid-infrared photothermal imaging of nitrile chameleons. Nat Methods 1-11 (2024) doi:10.1038 / s41592-023-02137-x.
[0554] [A51] Zhao J et al. Mid-infrared chemical imaging of intracellular tau fibrils using fluorescence-guided computational photothermal microscopy. Light Sci Appl 12, 147 (2023).
[0555] [A52] Mankar R et al. Polarization Sensitive Photothermal Mid-Infrared Spectroscopic Imaging of Human Bone Marrow Tissue. Appl Spectrosc 76, 508-518 (2022).
[0556] [A53] Samolis PD et al. Time-Resolved Mid-Infrared Photothermal Microscopy for Imaging Water-Embedded Axon Bundles. Anal. Chem. 95, 16514-16521 (2023).
[0557] [A54] Bazin D et al. Using mid infrared to perform investigations beyond the diffraction limits of microcristalline pathologies: advantages and limitation of Optical PhotoThermal IR spectroscopy. Comptes Rendus. Chimie 25, 105-131 (2022).
[0558] [A55] Xu S et al. The role of collagen in cancer: from bench to bedside. Journal of Translational Medicine 17, 309 (2019).
[0559] [A56] Zhu J et al. Mid-infrared multispectral confocal microscope using off-axis parabolic mirrors to study epiretinal membranes. Appl. Opt. 60, 8616 (2021).EXEMPLARY ASPECTS
[0560] In view of the described compositions, devices, systems, and methods, herein below are described certain more particularly described aspects of the inventions. The particularly recited aspects should not, however, be interpreted to have any limiting effect on any different claims containing different or more general teachings described herein or that the “particular” aspects are somehow limited in some way other than the inherent meanings of the language and formulas literally used therein.
[0561] Example 1: An imaging method, the method comprising simultaneously subjecting a sample to optical coherence tomography and photothermal spectroscopy.
[0562] Example 2: The method of any example herein, particularly example 1, the method comprising: irradiating at least a portion of the sample at a location with a pump signal from a pump light source (e.g., a pump laser), thereby inducing a photothermal response in the sample; and subsequently detecting and analyzing a signal from a probe light source (e.g., a probe laser) via optical coherence tomography that also illuminates the sample; wherein the photothermal response induced by the pump signal is transferred to the probe signal, which is detected as a signal that is analyzed to thereby provide imaging of the sample.
[0563] Example 3 : The method of any example herein, particularly example 1 or example 2, the method comprising: irradiating at least a portion of the sample at a location with a pump signal from a pump laser, thereby inducing a photothermal response in the sample; and subsequently detecting and analyzing a signal from a probe laser via optical coherence tomography that also illuminates the sample; wherein the photothermal response induced by the pump signal is transferred to the probe signal, which is detected as a signal that is analyzed to thereby provide imaging of the sample.
[0564] Example 4: The method of any example herein, particularly examples 2-3, wherein the method further comprises translocating the sample to thereby provide imaging of a plurality of locations of the sample.
[0565] Example 5: The method of any example herein, particularly examples 2-4, wherein the pump light source has a wavelength of from 2000 nm to 25,000 nm.
[0566] Example 6: The method of any example herein, particularly examples 2-5, wherein the pump light source has a wavelength of from 5000 to 20000 nm, from 5000 to 12000 nm, or from 2000 to 12000 nm.
[0567] Example 7: The method of any example herein, particularly examples 2-6, wherein the pump light source has a wavelength in the infrared region of the electromagnetic spectrum, such as the mid-infrared (MIR) region.Example 8: The method of any example herein, particularly examples 2-7, wherein the probe light source has a wavelength in the ultraviolet, visible, infrared, or other region of the electromagnetic spectrum.
[0568] Example 9: The method of any example herein, particularly examples 2-8, wherein the probe light source has a wavelength in the infrared region of the electromagnetic spectrum, such as the near-infrared (NIR) region.
[0569] Example 10: The method of any example herein, particularly examples 1-9, wherein the optical coherence tomography is leveraged to provide a common path interferometry for photothermal microscopy.
[0570] Example 11 : The method of any example herein, particularly examples 1-10, wherein the sample comprises a biological sample.
[0571] Example 12: The method of any example herein, particularly examples 1-11, wherein the sample comprises tissue.
[0572] Example 13: The method of any example herein, particularly examples 1-12, wherein the sample comprises ovarian tissue, endometrial tissue, cervical tissue, kidney tissue (e.g., kidney tissue features such as tubules and glomeruli),, bone marrow tissue, brain tissue (e.g., neuronal bundles in the brain), or a combination thereof.
[0573] Example 14: The method of any example herein, particularly examples 1-13, wherein the sample comprises collagen.
[0574] Example 15: The method of any example herein, particularly examples 1-14, wherein the sample comprises living cells, and the method is performed in situ on living cells.
[0575] Example 16: The method of any example herein, particularly examples 1-15, wherein the sample comprises inorganic compounds.
[0576] Example 17: The method of any example herein, particularly examples 1-16, wherein the sample comprises a polymer.
[0577] Example 18: The method of any example herein, particularly examples 1-17, wherein the sample comprises polystyrene, poly(methyl methacrylate) (PMMA), or a combination thereof.
[0578] Example 19: The method of any example herein, particularly examples 1-18, wherein the sample comprises battery materials, solar panel materials, materials used in energy research, organic materials, unknown chemicals of interest, composite materials, materials used in art, historical artifacts and / or documents, diagnostically relevant constituents, heterogeneous structures, liquids, gases, oils, or a combination thereof.
[0579] Example 20: The method of any example herein, particularly examples 1-19, wherein the method comprises photothermal mid-infrared spectroscopy coupled to optical coherencetomography, such as Fourier-domain optical coherence tomography.
[0580] Example 21: The method of any example herein, particularly examples 1-20, wherein the method combines the high-resolution structural imaging of optical coherence tomography (OCT) with the biochemical contrast of mid-infrared photothermal detection.
[0581] Example 22: The method of any example herein, particularly examples 1-21, wherein the method is label-free.
[0582] Example 23: The method of any example herein, particularly examples 1-22, wherein the method is substantially free of any added contrast agents.
[0583] Example 24: The method of any example herein, particularly examples 1-23, wherein the method has subcellular resolution.
[0584] Example 25: The method of any example herein, particularly examples 1-24, wherein the method has subcellular resolution and label-free specificity.
[0585] Example 26: The method of any example herein, particularly examples 1-25, wherein the method further comprises use of machine-learning algorithms to further analyze the images.
[0586] Example 27: The method of any example herein, particularly examples 1-26, wherein three-dimensional (3D) data are obtained.
[0587] Example 28: The method of any example herein, particularly examples 1-27, wherein two-dimensional (2D) mid-infrared data and three-dimensional OCT data are obtained simultaneously.
[0588] Example 29: The method of any example herein, particularly examples 1-28, wherein the mid-infrared and OCT data are combined into one dataset.
[0589] Example 30: The method of any example herein, particularly examples 1-29, wherein 3D data from OCT is used to complement 2D data from the mid-infrared.
[0590] Example 31: The method of any example herein, particularly examples 1-30, wherein 2D chemical information from mid-infrared spectroscopy complements the morphological information from OCT.
[0591] Example 32: The method of any example herein, particularly examples 1-31, wherein the 3D imaging from OCT complements the chemical maps from the mid-infrared.
[0592] Example 33: The method of any example herein, particularly examples 1-32, the combination of the two methods provides more information than each method alone.
[0593] Example 34: A device for performing the methods of any example herein, particularly examples 1-33.
[0594] Example 35: A photothermal spectroscopy -tomography device comprising: a photothermal spectrometer integrated with an optical coherence topographer; wherein the deviceis configured to: irradiate at least a portion of a sample at a location with a pump signal from a pump light source (e.g., a pump laser), thereby inducing a photothermal response in the sample; and subsequently detect and analyze a probe signal from a probe light source (e.g., a probe laser) via optical coherence tomography that simultaneously illuminates the sample; wherein the photothermal response induced by the pump signal is transferred to the probe signal, which is detected as a signal that is analyzed to thereby provide imaging of the sample.
[0595] Example 36: The device of any example herein, particularly example 35, wherein the device is configured to perform the methods of any example herein, particularly examples 1-33.
[0596] Example 37: The device of any example herein, particularly examples 34-36, wherein the device comprises: a pump light source (e.g., a pump laser); a probe light source (e.g., a probe laser); an optical component; and a detector; the pump light source being configured to provide a pump signal; the probe light source being configured to provide a probe signal; the optical component being configured to receive the pump signal and probe signal and focus each onto a sample, and subsequently transmit a measured signal to the detector.
[0597] Example 38: The device of any example herein, particularly example 37, wherein the device further comprises an optical fiber, a dichroic beam combiner, a light-routing component, a collimation optic, or a combination thereof.
[0598] Example 39: The device of any example herein, particularly example 37 or example 38, wherein the device further comprises an optical fiber, a single mode fiber, a dichroic beam combiner, a beam splitter, a beam circulator, a multi-mode fiber, a mirror such as an off-axis parabolic mirror, a collimator, an objective, or a combination thereof.
[0599] Example 40: The device of any example herein, particularly examples 34-39, wherein the device comprises: a pump light source (e.g., a pump laser); a probe light source (e.g., a probe laser); a single mode fiber circulator; a dichroic beam combiner; an off-axis parabolic mirror; and a detector; the pump light source being configured to provide a pump signal; the off-axis parabolic mirror being configured to receive the pump signal and focus the pump signal onto the sample; the probe light source being configured to provide a probe signal; the single mode fiber circulator being configured to receive the probe signal from the probe light source and transmit the probe signal to the dichroic beam combiner; the dichroic beam combiner being configured to receive the probe signal from the single mode fiber circulator, and transmit the probe signal to the sample; and the dichroic beam combiner being further configured to subsequently receive and transmit a measured signal to the detector.
[0600] Example 41: The device of any example herein, particularly examples 34-40, further comprising one or more focusing elements (e.g., collimator, objective, lens, mirror, etc.).Example 42: The device of any example herein, particularly examples 34-41, further comprising one or more additional components, such as a beam splitter, a beam circulator, a multi-mode fiber, or a combination thereof.
[0601] Example 43: The device of any example herein, particularly examples 34-42, further comprising a movable stage, the sample being supported by the movable stage.
[0602] Example 44: The device of any example herein, particularly example 43, further comprising a means for translocating the movable stage, thereby translocating the sample to thereby provide hyperspectral imaging of a plurality of locations of the sample.
[0603] Example 45: The device of any example herein, particularly examples 34-44, wherein the pump light source has a wavelength of from 2000 nm to 25,000 nm.
[0604] Example 46: The device of any example herein, particularly examples 34-45, wherein the pump light source has a wavelength of from 5000 to 20000 nm, from 5000 to 12000 nm, or from 2000 to 12000 nm.
[0605] Example 47: The device of any example herein, particularly examples 34-46, wherein the pump light source has a wavelength in the infrared region of the electromagnetic spectrum, such as the mid-infrared (MIR) region.
[0606] Example 48: The device of any example herein, particularly examples 34-47, wherein the pump light source comprises a laser, a light emitting diode (LED), or a combination thereof.
[0607] Example 49: The device of any example herein, particularly examples 34-48, wherein the pump light source comprises a laser.
[0608] Example 50: The device of any example herein, particularly examples 34-49, wherein the pump light source comprises a QCL (e.g., a pulsed QCL), a supercontinuum laser, an OPO laser, a femtosecond laser, a picosecond laser, a comb laser, or a combination thereof.
[0609] Example 51: The device of any example herein, particularly examples 34-50, further comprising a modulator coupled to the pump light source, the waveform generator configured to modulate the pump signal.
[0610] Example 52: The device of any example herein, particularly example 51, wherein the modulator comprises a waveform generator.
[0611] Example 53: The device of any example herein, particularly examples 34-52, wherein the probe light source comprises a laser, a black body source, a light emitting diode (LED), a continuous wave (CW) light source, a pulsed light source, or a combination thereof.
[0612] Example 54: The device of any example herein, particularly examples 34-53, wherein the probe light source comprises a laser, such as a swept source laser and / or a broadband laser.
[0613] Example 55: The device of any example herein, particularly examples 34-54, wherein theprobe light source has a wavelength in the ultraviolet, visible, infrared, or other region of the electromagnetic spectrum.
[0614] Example 56: The device of any example herein, particularly examples 34-55, wherein the probe light source has a wavelength in the infrared region of the electromagnetic spectrum, such as the near-infrared (NIR) region.
[0615] Example 57: The device of any example herein, particularly examples 34-56, wherein the device further comprises an optical fiber, for example that is configured to transmit light.
[0616] Example 58: The device of any example herein, particularly example 57, wherein the optical fiber comprises a single mode fiber, a chalcogenide fiber, a multi-mode fiber, a hollow core fiber, a photonic crystal fiber, a flexible fiber optic, or a combination thereof.
[0617] Example 59: The device of any example herein, particularly examples 34-58, wherein the device further comprises a light-routing component, for example that is used to direct light to the detector.
[0618] Example 60: The device of any example herein, particularly example 59, wherein the light-routing component comprises an optical coupler, a fiber coupler, a free-space coupler, or a combination thereof.
[0619] Example 61: The device of any example herein, particularly examples 59-60, wherein the light-routing component is replaced by a circulator, a beam splitter, a beam combiner, or a combination thereof.
[0620] Example 62: The device of any example herein, particularly examples 34-61, wherein the device further comprises a condenser configured to couple the pump signal into the optical fiber.
[0621] Example 63 : The device of any example herein, particularly example 62, wherein the condenser is configured to receive the pump signal from the pump light source and mode match the pump signal with the optical fiber before the pump signal enters the optical fiber.
[0622] Example 64: The device of any example herein, particularly example 62 or example 63, wherein the condenser is an aspheric condenser, a reflective mirror, a lens (e.g., a set of lenses), an objective (e.g., a Cassegrain objective), or a combination thereof.
[0623] Example 65: The device of any example herein, particularly examples 62-64, wherein the condenser is an aspheric condenser.
[0624] Example 66: The device of any example herein, particularly examples 34-65, further comprising a fixed focus collimator configured to receive the probe signal from the light-routing component, focus the probe signal, and transmit the focused probe signal to the dichroic beam combiner.
[0625] Example 67: The device of any example herein, particularly examples 34-66, furthercomprising a variable focus collimator configured to receive the probe signal grom the fiber coupler, focus the probe signal, and transmit the focused probe signal to the dichroic beam combiner.
[0626] Example 68: The device of any example herein, particularly examples 34-67, wherein the dichroic beam combiner comprises a short-pass dichroic beam combiner and / or a long-pass dichroic beam combiner.
[0627] Example 69: The device of any example herein, particularly examples 34-68, wherein the dichroic beam combiner comprises a short-pass dichroic beam combiner.
[0628] Example 70: The device of any example herein, particularly examples 34-69, wherein the dichroic beam combiner is further configured to align the pump signal from the optical fiber and the probe signal from the light-routing component.
[0629] Example 71: The device of any example herein, particularly examples 34-70, the device further comprises a focusing optic, which can, for example, be used to focus the pump beam and / or the probe beam.
[0630] Example 72: The device of any example herein, particularly example 71, wherein the focusing optic comprises a mirror, such as a curved mirror.
[0631] Example 73: The device of any example herein, particularly example 71 or example 72, wherein the focusing optic comprises an off-axis parabolic mirror.
[0632] Example 74: The device of any example herein, particularly examples 34-73, wherein the device further comprises a movable stage, the focusing optic being mounted on the movable stage.
[0633] Example 75: The device of any example herein, particularly example 74, wherein the movable stage comprises a set of cascaded rotational-translation stages.
[0634] Example 76: The device of any example herein, particularly example 74 or example 75, wherein the device further comprises a means for translating the movable stage, thereby translocating the focusing optic to thereby provide imaging of a plurality of locations of the sample.
[0635] Example 77: The device of any example herein, particularly examples 34-76, wherein the device further comprises a means for translating the pump light source and / or probe light source, for example laterally, to thereby provide imaging of a plurality of locations of the sample.
[0636] Example 78: The device of any example herein, particularly examples 34-77, wherein the detector comprises a photodiode (e.g., an array of photodiodes), a detection element (e.g., an array of detection elements), a camera system, or a combination thereof.
[0637] Example 79: The device of any example herein, particularly examples 34-78, wherein thedetector comprises a photodiode.
[0638] Example 80: The device of any example herein, particularly examples 34-79, further comprising a computing device operably coupled to one or more device components.
[0639] Example 81: The device of any example herein, particularly examples 34-80, wherein the sample comprises tissue.
[0640] Example 82: The device of any example herein, particularly examples 34-81, wherein the sample comprises ovarian tissue, endometrial tissue, cervical tissue, kidney tissue (e.g., kidney tissue features such as tubules and glomeruli), bone marrow tissue, brain tissue (e.g., neuronal bundles in the brain), or a combination thereof.
[0641] Example 83: The device of any example herein, particularly examples 34-82, wherein the sample comprises collagen.
[0642] Example 84: The device of any example herein, particularly examples 34-83, wherein the device enables in vivo label-free imaging of biological tissue.
[0643] Example 85: The device of any example herein, particularly examples 34-84, wherein the device is configured to be coupled to an endoscope to provide in situ imaging of biological tissue.
[0644] Example 86: The device of any example herein, particularly examples 34-85, wherein the device enables label free characterization of inorganic and organic material.
[0645] Example 87: The device of any example herein, particularly examples 34-86, wherein the device is diagnostically useful.
[0646] Example 88: The device of any example herein, particularly examples 34-87, wherein the device provides structural and chemical information.
[0647] Example 89: The device of any example herein, particularly examples 34-88, Wherein the device provides molecular information relevant for disease analysis.
[0648] Example 90: The device of any example herein, particularly examples 34-89, wherein the sample comprises inorganic compounds.
[0649] Example 91: The device of any example herein, particularly examples 34-90, wherein the sample comprises a polymer.
[0650] Example 92: The device of any example herein, particularly examples 34-91, wherein the sample comprises polystyrene, poly(methyl methacrylate) (PMMA), or a combination thereof.
[0651] Example 93: The device of any example herein, particularly examples 34-92, the sample comprises battery materials, solar panel materials, materials used in energy research, organic materials, unknown chemicals of interest, composite materials, materials used in art, historical artifacts and / or documents, diagnostically relevant constituents, heterogeneous structures,liquids, gases, oils, or a combination thereof.
[0652] Example 94: The device of any example herein, particularly examples 34-93, the device being as shown in Figure 4.
[0653] Example 95: The device of any example herein, particularly examples 34-94, wherein the device couples photothermal mid-infrared spectroscopy to optical coherence tomography, such as Fourier-domain optical coherence tomography.
[0654] Example 96: The device of any example herein, particularly examples 34-95, wherein the device combines the high-resolution structural imaging of optical coherence tomography (OCT) with the biochemical contrast of mid-infrared photothermal detection.
[0655] Example 97: The device of any example herein, particularly examples 34-96, wherein the device is configured such that optical coherence tomography is leveraged to provide a common path interferometry for photothermal microscopy.
[0656] Example 98: The device of any example herein, particularly examples 34-97, wherein the device has subcellular resolution.
[0657] Example 99: The device of any example herein, particularly examples 34-98, wherein the device is configured to be handheld.
[0658] Example 100: The device of any example herein, particularly examples 34-99, wherein the device is portable.
[0659] Example 101: The device of any example herein, particularly examples 34-100, wherein the device is a point-of-care device.
[0660] Example 102: The device of any example herein, particularly examples 34-101, wherein the device provides 3D structural information.
[0661] Example 103: The device of any example herein, particularly examples 34-102, wherein the device provides chemical information.
[0662] Example 104: The device of any example herein, particularly examples 34-103, wherein the device provides simultaneous 3D and chemical information.
[0663] Example 105: The device of any example herein, particularly examples 34-104, wherein the device provides diagnostically relevant molecular information.
[0664] Example 106: The device of any example herein, particularly examples 34-105, wherein the device is flexible, easy to use, provides immediate feedback, provides diagnostic information, assists with real-time analysis, provides label-free contrast, or a combination thereof.
[0665] Example 107: The device of any example herein, particularly examples 34-106, wherein the device can be in contact with a human in a safe manner.Example 108: The device of any example herein, particularly examples 34-107, wherein the device is miniaturized and compact.
[0666] Example 109: A method of use of the device of any example herein, particularly examples 34-108.
[0667] Example 110: The method of any example herein, particularly example 109, wherein the method comprises using the device to perform the methods of any example herein, particularly examples 1-33.
[0668] Example 111: The method of any example herein, particularly example 109 or example 110, wherein the method comprises using the device in a clinical or field setting.
[0669] Example 112: The method of any example herein, particularly examples 109-111, wherein the method comprises using the device in a point-of-care setting.
[0670] Example 113: The method of any example herein, particularly examples 109-112, wherein the method comprises using the device in a biomedical setting or application.
[0671] Example 114: The method of any example herein, particularly examples 109-113, wherein the method comprises using the device for biological research, clinical diagnostics, or a combination thereof.
[0672] Example 115: The method of any example herein, particularly examples 109-114, wherein the method comprises using the device for diagnostic imaging of complex biological systems.
[0673] Example 116: The method of any example herein, particularly examples 109-115, wherein the method further comprises collecting the sample.
[0674] Example 117: The method of any example herein, particularly examples 109-116, wherein the method comprises diagnosing and / or monitoring a condition or disease in a subject based on a property of the sample.
[0675] Example 118: The method of any example herein, particularly examples 109-117, wherein the method comprises using the device in biomedical and / or clinical applications, for example for disease visualization and diagnosis.
[0676] Example 119: The method of any example herein, particularly examples 109-118, wherein the method comprises using the device to provide rapid diagnosis at a point of care and / or clinical setting.
[0677] Example 120: The method of any example herein, particularly examples 109-119, wherein the method is minimally invasive.
[0678] Example 121: The method of any example herein, particularly examples 109-120, further comprising selecting a course of therapy for the subject based on the property of the sample.Example 122: The method of any example herein, particularly examples 109-121, wherein the method comprises using the device for material characterization, using the device for field characterization of oil samples, using the device for energy research, using the device for battery characterization, using the device for solar panel characterization, using the device for field identification of hazardous materials, using the device for field identification of unknown chemicals, using the device for field identification of historical artifacts, or a combination thereof.
[0679] Example Al: A spectroscopic imaging device comprising:
[0680] a pump light source (e.g., laser);
[0681] a probe light source (e.g., laser);
[0682] an optical fiber (e.g., a single mode fiber);
[0683] a light-routing component (e.g., a fiber coupler);
[0684] a dichroic beam combiner;
[0685] a collimation optic (e.g., a reflective collimator);
[0686] a focusing optic (e.g., an off-axis parabolic mirror); and
[0687] a detector;
[0688] the pump light source being configured to provide a pump signal;
[0689] the optical fiber being configured to receive the pump signal from the pump light source and transmit the pump signal to a dichroic beam combiner;
[0690] the probe light source being configured to provide a probe signal;
[0691] the light-routing component being configured to receive the probe signal from the probe light source and transmit the probe signal to the dichroic beam combiner;
[0692] the collimation optic being configured to receive the pump signal from the optical fiber and transmit the pump signal to the dichroic beam combiner;
[0693] the dichroic beam combiner being configured to receive and combine the pump signal from the collimation optic and the probe signal from the light-routing component, and transmit the combined signal to the focusing optic;
[0694] the focusing optic being configured to receive the combined signal and focus the combined signal onto a sample, and subsequently transmit a measured signal back through the dichroic beam combiner to the light-routing component and then to a detector;
[0695] wherein the device is configured to:
[0696] irradiate at least a portion of a sample at a location with a pump signal, thereby inducing a photothermal response in the sample; and
[0697] subsequently detect and analyze a signal from a probe signal that simultaneouslyilluminates at least the portion of the sample;
[0698] wherein the photothermal response induced by the pump signal is transferred to the probe signal, which is subsequently photodetected as a signal that is analyzed to thereby provide imaging of the sample.
[0699] Example A2: The device of any example herein, particularly example Al, further comprising one or more focusing elements (e.g., collimator, objective, lens, mirror, etc.).
[0700] Example A3: The device of any example herein, particularly example Al or example A2, further comprising a movable stage, the sample being supported by the movable stage.
[0701] Example A4: The device of any example herein, particularly example A3, further comprising a means for translocating the movable stage, thereby translocating the sample to thereby provide imaging of a plurality of locations of the sample.
[0702] Example A5: The device of any example herein, particularly examples A1-A4, wherein the pump light source has a wavelength of from 2000 to 25,000 nm.
[0703] Example A6: The device of any example herein, particularly examples A1-A5, wherein the pump light source has a wavelength of from 5000 to 20000 nm, from 5000 to 12000 nm, or from 2000 to 12000 nm.
[0704] Example A7: The device of any example herein, particularly examples A1-A6, wherein the pump light source has a wavelength in the infrared region of the electromagnetic spectrum, such as the mid-infrared region.
[0705] Example A8: The device of any example herein, particularly examples A1-A7, wherein the pump light source comprises a laser, a black body source, a light emitting diode (LED), or a combination thereof.
[0706] Example A9: The device of any example herein, particularly examples A1-A8, wherein the pump light source comprises a laser.
[0707] Example A10: The device of any example herein, particularly example A9, wherein the pump light source comprises a QCL (e.g., a pulsed QCL), a supercontinuum laser, an OPO laser, a femtosecond laser, a picosecond laser, a comb laser, or a combination thereof.
[0708] Example All: The device of any example herein, particularly examples A1-A10, further comprising a modulator coupled to the pump light source, the waveform generator configured to modulate the pump signal.
[0709] Example A12: The device of any example herein, particularly example All, wherein the modulator comprises a waveform generator.
[0710] Example A13: The device of any example herein, particularly examples A1-A12, wherein the probe light source comprises a laser, a black body source, a light emitting diode(LED), a continuous wave (CW) light source, a pulsed light source, or a combination thereof. Example A14: The device of any example herein, particularly examples A1-A13, wherein the probe light source comprises a laser.
[0711] Example A15: The device of any example herein, particularly examples Al-AM, wherein the probe light source has a wavelength in the ultraviolet, visible, infrared, or other region of the electromagnetic spectrum.
[0712] Example A16: The device of any example herein, particularly examples A1-A15, wherein the probe light source has a wavelength in visible region (e.g., from 400 to 700 nm) of the electromagnetic spectrum.
[0713] Example A17: The device of any example herein, particularly examples A1-A16, wherein the optical fiber comprises a chalcogenide fiber.
[0714] Example Al 8: The device of any example herein, particularly examples Al -Al 7, wherein the optical fiber comprises a single mode fiber (e.g., a mid-infrared (MIR) chalcogenide single mode fiber), a multi-mode fiber, a hollow core fiber, a photonic crystal fiber, or a combination thereof.
[0715] Example A19: The device of any example herein, particularly examples A1-A18, wherein the optical fiber is a flexible fiber optic.
[0716] Example A20: The device of any example herein, particularly examples A1-A19, wherein the light-routing component comprises an optical coupler, a fiber coupler, a free-space coupler, or a combination thereof.
[0717] Example A21: The device of any example herein, particularly examples A1-A20, wherein the light-routing component is replaced by a circulator, a beam splitter, a beam combiner, or a combination thereof.
[0718] Example A22: The device of any example herein, particularly examples A1-A21, wherein the device further comprises a condenser configured to couple the pump signal into the optical fiber.
[0719] Example A23 : The device of any example herein, particularly example A22, wherein the condenser is configured to receive the pump signal from the pump light source and mode match the pump signal with the optical fiber before the pump signal enters the optical fiber.
[0720] Example A24: The device of any example herein, particularly example A22 or example A23, wherein the condenser is an aspheric condenser, a reflective mirror, a lens (e.g., a set of lenses), an objective (e.g., a Cassegrain objective), or a combination thereof.
[0721] Example A25: The device of any example herein, particularly examples A22-A24, wherein the condenser is an aspheric condenser.Example A26: The device of any example herein, particularly examples A1-A25, further comprising a fixed focus collimator configured to receive the probe signal from the light-routing component, focus the probe signal, and transmit the focused probe signal to the dichroic beam combiner.
[0722] Example A27: The device of any example herein, particularly examples A1-A26, further comprising a variable focus collimator configured to receive the probe signal grom the fiber coupler, focus the probe signal, and transmit the focused probe signal to the dichroic beam combiner.
[0723] Example A28: The device of any example herein, particularly examples A1-A27, wherein the dichroic beam combiner comprises a short-pass dichroic beam combiner and / or a long-pass dichroic beam combiner.
[0724] Example A29: The device of any example herein, particularly examples A1-A28, wherein the dichroic beam combiner comprises a short-pass dichroic beam combiner.
[0725] Example A30: The device of any example herein, particularly examples A1-A29, wherein the dichroic beam combiner is further configured to align the pump signal from the optical fiber and the probe signal from the light-routing component.
[0726] Example A31: The device of any example herein, particularly examples A1-A30, wherein the focusing optic comprises an off-axis parabolic mirror.
[0727] Example A32: The device of any example herein, particularly examples A1-A31, wherein the spectroscopic imaging device comprises:
[0728] a pump laser;
[0729] a probe laser;
[0730] a single mode fiber;
[0731] a fiber coupler;
[0732] a dichroic beam combiner;
[0733] a reflective collimator;
[0734] an off-axis parabolic mirror; and
[0735] a detector;
[0736] the pump laser being configured to provide a pump signal;
[0737] the single mode fiber being configured to receive the pump signal from the pump laser and transmit the pump signal to a dichroic beam combiner;
[0738] the probe laser being configured to provide a probe signal;
[0739] the fiber coupler being configured to receive the probe signal from the probe laser and transmit the probe signal to the dichroic beam combiner;the reflective collimator being configured to receive the pump signal from the single mode fiber and transmit the pump signal to the dichroic beam combiner;
[0740] the dichroic beam combiner being configured to receive and combine the pump signal from the reflective collimator and the probe signal from the fiber coupler, and transmit the combined signal to the off-axis parabolic mirror;
[0741] the off-axis parabolic mirror being configured to receive the combined signal and focus the combined signal onto a sample, and subsequently transmit a measured signal back through the dichroic beam combiner to the fiber coupler and then to a detector;
[0742] wherein the device is configured to:
[0743] irradiate at least a portion of a sample at a location with a pump signal, thereby inducing a photothermal response in the sample; and
[0744] subsequently detect and analyze a signal from a probe signal that simultaneously illuminates at least the portion of the sample;
[0745] wherein the photothermal response induced by the pump signal is transferred to the probe signal, which is subsequently photodetected as a signal that is analyzed to thereby provide imaging of the sample
[0746] Example A33: The device of any example herein, particularly examples A1-A32, further comprising a movable stage, the focusing optic being mounted on the movable stage.
[0747] Example A34: The device of any example herein, particularly example A33, wherein the movable stage comprises a set of cascaded rotational-translation stages.
[0748] Example A35: The device of any example herein, particularly example A33 or example A34, wherein the device further comprises a means for translating the movable stage, thereby translocating the focusing optic to thereby provide imaging of a plurality of locations of the sample.
[0749] Example A36: The device of any example herein, particularly examples A1-A35, further comprising a means for translating the pump light source and / or probe light source, for example laterally, to thereby provide imaging of a plurality of locations of the sample.
[0750] Example A37: The device of any example herein, particularly examples A1-A36, wherein the detector comprises a photodiode (e.g., an array of photodiodes), a detection element (e.g., an array of detection elements), a camera system, or a combination thereof.
[0751] Example A38: The device of any example herein, particularly examples A1-A37, wherein the detector comprises a photodiode.
[0752] Example A39: The device of any example herein, particularly examples A1-A38, further comprising a computing device operably coupled to one or more device components.Example A40: The device of any example herein, particularly examples A1-A38, wherein the sample comprises a biological sample.
[0753] Example A41: The device of any example herein, particularly examples A1-A40, wherein the sample comprises tissue.
[0754] Example A42: The device of any example herein, particularly examples A1-A41, wherein the sample comprises ovarian tissue, endometrial tissue, cervical tissue, kidney tissue, bone marrow tissue, brain tissue, or a combination thereof.
[0755] Example A43: The device of any example herein, particularly examples A1-A42, wherein the sample comprises collagen.
[0756] Example A44: The device of any example herein, particularly examples A1-A43, wherein the device enables in vivo label-free imaging of biological tissue.
[0757] Example A45: The device of any example herein, particularly examples A1-A44, wherein the device is configured to be coupled to an endoscope to provide in situ imaging of biological tissue.
[0758] Example A46: The device of any example herein, particularly examples A1-A45, wherein the sample comprises inorganic compounds.
[0759] Example A47: The device of any example herein, particularly examples A1-A46, wherein the device enables label-free characterization of inorganic and organic material.
[0760] Example A48: The device of any example herein, particularly examples A1-A47, wherein the sample comprises a polymer.
[0761] Example A49: The device of any example herein, particularly examples A1-A48, wherein the sample comprises polystyrene, poly(methyl methacrylate) (PMMA), or a combination thereof.
[0762] Example A50: The device of any example herein, particularly examples A1-A49, wherein the sample comprises battery materials, solar panel materials, materials used in energy research, organic materials, unknown chemicals of interest, composite materials, materials used in art, historical artifacts and / or documents, diagnostically relevant constituents, heterogeneous structures, liquids, gases, oils, or a combination thereof.
[0763] Example A51: The device of any example herein, particularly examples A1-A50, the device being as shown in Figure 11.
[0764] Example A52: The device of any example herein, particularly examples A1-A51, wherein the device comprises a photothermal mid-infrared spectroscopic imaging device.
[0765] Example A53: The device of any example herein, particularly examples A1-A52, wherein the device is compact.Example A54: The device of any example herein, particularly examples A1-A53, wherein the device is smaller than a traditional bench-top device.
[0766] Example A55: The device of any example herein, particularly examples A1-A54, wherein the device has a footprint that is 10 sq. ft or less in size, such as 4 sq. ft. or less or 2 sq. ft. or less in size.
[0767] Example A56: The device of any example herein, particularly examples A1-A55, wherein the device has subcellular resolution.
[0768] Example A57: The device of any example herein, particularly examples A1-A56, wherein the device has comparable or better performance than a state-of-the-art benchtop system.
[0769] Example A58: The device of any example herein, particularly examples A1-A57, wherein the device is configured to be handheld.
[0770] Example A59: The device of any example herein, particularly examples A1-A58, wherein the device is portable.
[0771] Example A60: The device of any example herein, particularly examples A1-A59, wherein the device is a point-of-care device.
[0772] Example A61: The device of any example herein, particularly examples A1-A60, wherein the device is flexible, easy to use, provides immediate feedback, provides diagnostic information, assists with real-time analysis, provides label-free contrast, or a combination thereof.
[0773] Example A62: The device of any example herein, particularly examples A1-A61, wherein the device can be in contact with a human in a safe manner.
[0774] Example A63 : A method of use of the device of any example herein, particularly examples A1-A62.
[0775] Example A64: The method of any example herein, particularly example A63, wherein the method comprises using the device in a clinical or field setting.
[0776] Example A65: The method of any example herein, particularly example A63 or example A64, wherein the method comprises using the device in a point-of-care setting.
[0777] Example A66: The method of any example herein, particularly examples A63-A65, wherein the method comprises using the device in a hospital, clinical setting, field application in the plastics and materials industries, or a combination thereof.
[0778] Example A67: The method of any example herein, particularly examples A63-A66, wherein the method comprises using the device in a biomedical setting or application.
[0779] Example A68: The method of any example herein, particularly examples A63-A67,wherein the method further comprises collecting the sample.
[0780] Example A69: The method of any example herein, particularly examples A63-A68, wherein the method comprises diagnosing and / or monitoring a condition or disease in a subject based on a property of the sample.
[0781] Example A70: The method of any example herein, particularly examples A63-A69, wherein the method is non-invasive.
[0782] Example A71: The method of any example herein, particularly examples A63-A70, further comprising selecting a course of therapy for the subject based on the property of the sample.
[0783] Example A72: The method of any example herein, particularly examples A63-A71, wherein the method comprises using the device for material characterization, using the device for field characterization of oil samples, using the device for energy research, using the device for battery characterization, using the device for solar panel characterization, using the device for field identification of hazardous materials, using the device for field identification of unknown chemicals, using the device for field identification of historical artifacts, or a combination thereof.
[0784] Example A73: A spectroscopic imaging method, wherein the method comprises using the device of any example herein, particularly examples A1-A62.
[0785] Example A74: The method of any example herein, particularly example A73, the method comprising: irradiating at least a portion of the sample at a location with the pump signal from a pump light source, thereby inducing a photothermal response in the sample; and subsequently detecting and analyzing a probe signal from the probe light source that simultaneously illuminates the sample; wherein the photothermal response induced by the pump signal is transferred to the probe signal, which is subsequently photodetected as a signal that is analyzed to thereby provide imaging of the sample.
[0786] Example A75: The method of any example herein, particularly example A74, wherein the method further comprises translocating the sample and / or at least a portion of the device to thereby provide imaging of a plurality of locations of the sample.
[0787] Example A76: The method of any example herein, particularly examples A73-A75, wherein the pump light source has a wavelength of from 2000 nm to 25,000 nm.
[0788] Example A77: The method of any example herein, particularly examples A73-A76, wherein the pump light source has a wavelength of from 5000 to 20000 nm, from 5000 to 12000 nm, or from 2000 to 12000 nm.
[0789] Example A78: The method of any example herein, particularly examples A73-A77,wherein the pump light source has a wavelength in the infrared region of the electromagnetic spectrum, such as the mid-infrared region.
[0790] Example A79: The method of any example herein, particularly examples A73-A78, wherein the probe light source has a wavelength in the ultraviolet, visible, infrared, or other region of the electromagnetic spectrum.
[0791] Example A80: The method of any example herein, particularly examples A73-A79, wherein the probe light source has a wavelength in the visible region (e.g., from 400 to 700 nm) of the electromagnetic spectrum.
[0792] Example A81: The method of any example herein, particularly examples A73-A80, wherein the sample comprises a biological sample.
[0793] Example A82: The method of any example herein, particularly examples A73-A81, wherein the sample comprises tissue.
[0794] Example A83: The method of any example herein, particularly examples A73-A82, wherein the sample comprises ovarian tissue, endometrial tissue, cervical tissue, kidney tissue, bone marrow tissue, brain tissue, or a combination thereof.
[0795] Example A84: The method of any example herein, particularly examples A73-A83, wherein the sample comprises collagen.
[0796] Example A85: The method of any example herein, particularly examples A73-A84, wherein the sample comprises living cells, and the method is performed in situ on living cells.
[0797] Example A86: The method of any example herein, particularly examples A73-A85, wherein the sample comprises inorganic compounds.
[0798] Example A87: The method of any example herein, particularly examples A73-A86, wherein the sample comprises a polymer.
[0799] Example A88: The method of any example herein, particularly examples A73-A87, wherein the sample comprises polystyrene, poly(methyl methacrylate) (PMMA), or a combination thereof.
[0800] Example A89: The method of any example herein, particularly examples A73-A88, wherein the sample comprises battery materials, solar panel materials, materials used in energy research, organic materials, unknown chemicals of interest, composite materials, materials used in art, historical artifacts and / or documents, diagnostically relevant constituents, heterogeneous structures, liquids, gases, oils, or a combination thereof.
[0801] Example A90: The method of any example herein, particularly examples A73-A89, wherein the method comprises photothermal mid-infrared spectroscopy.
[0802] Example A91: The method of any example herein, particularly examples A73-A90,wherein the method is label-free.
[0803] Example A92: The method of any example herein, particularly examples A73-A91, wherein the method is substantially free of any added contrast agents.
[0804] Example A93: The method of any example herein, particularly examples A73-A92, wherein the method has subcellular resolution.
[0805] Other advantages which are obvious and which are inherent to the invention will be evident to one skilled in the art. It will be understood that certain features and sub-combinations are of utility and may be employed without reference to other features and sub-combinations. This is contemplated by and is within the scope of the claims. Since many possible embodiments may be made of the invention without departing from the scope thereof, it is to be understood that all matter herein set forth or shown in the accompanying drawings is to be interpreted as illustrative and not in a limiting sense.
[0806] The devices and methods of the appended claims are not limited in scope by the specific devices and methods described herein, which are intended as illustrations of a few aspects of the claims and any devices and methods that are functionally equivalent are intended to fall within the scope of the claims. Various modifications of the devices and methods in addition to those shown and described herein are intended to fall within the scope of the appended claims. Further, while only certain representative method steps disclosed herein are specifically described, other combinations of the method steps also are intended to fall within the scope of the appended claims, even if not specifically recited. Thus, a combination of steps, elements, components, or constituents may be explicitly mentioned herein or less, however, other combinations of steps, elements, components, and constituents are included, even though not explicitly stated.
Claims
CLAIMSWhat is claimed is:
1. An imaging method comprising simultaneously subjecting a sample to Fourier-domain optical coherence tomography and photothermal mid-infrared spectroscopy, the method comprising:irradiating at least a portion of the sample at a location with a pump signal from a pump light source (e.g., a pump laser), thereby inducing a photothermal response in the sample, wherein the pump light source has a wavelength in the mid-infrared (MIR) region of the electromagnetic spectrum; andsubsequently detecting and analyzing a signal from a probe light source (e.g., a probe laser) via Fourier-domain optical coherence tomography that also illuminates the sample;wherein the photothermal response induced by the pump signal is transferred to the probe signal, which is detected as a signal that is analyzed to thereby provide imaging of the sample; andwherein the method is label-free and / or wherein the method is substantially free of any added contrast agents.
2. The method of claim 1, the method comprising:irradiating at least a portion of the sample at a location with a pump signal from a pump laser, thereby inducing a photothermal response in the sample, wherein the pump laser has a wavelength in the mid-infrared (MIR) region of the electromagnetic spectrum; and subsequently detecting and analyzing a signal from a probe laser via Fourier-domain optical coherence tomography that also illuminates the sample;wherein the photothermal response induced by the pump signal is transferred to the probe signal, which is detected as a signal that is analyzed to thereby provide imaging of the sample; andwherein the method is label-free and / or wherein the method is substantially free of any added contrast agents.
3. The method of claim 1 or claim 2, wherein the method further comprises translocating the sample to thereby provide imaging of a plurality of locations of the sample.
4. The method of any one of claims 1-3, wherein the pump light source has a wavelength of from 2000 nm to 25,000 nm.
5. The method of any one of claims 1-4, wherein the Fourier-domain optical coherence tomography is leveraged to provide a common path interferometry for photothermal midinfrared microscopy.
6. The method of any one of claims 1-5, wherein the sample comprises a biological sample.
7. The method of any one of claims 1-6, wherein the sample comprises living cells, and the method is performed in situ on living cells.
8. The method of any one of claims 1-7, wherein the method combines the high-resolution structural imaging of Fourier-domain optical coherence tomography (FD-OCT) with the biochemical contrast of mid-infrared photothermal detection.
9. The method of any one of claims 1-8, wherein the method is label-free.
10. The method of any one of claims 1-9, wherein two-dimensional (2D) mid-infrared data and three-dimensional FD-OCT data are obtained simultaneously.
11. A device for performing the methods of any one of claims 1-10.
12. A photothermal spectroscopy -tomography device comprising:a photothermal mid-infrared spectrometer integrated with an Fourier-domain optical coherence topographer;wherein the device is configured to:irradiate at least a portion of a sample at a location with a pump signal from a pump light source (e.g., a pump laser), thereby inducing a photothermal response in the sample, wherein the pump light source has a wavelength in the mid-infrared (MIR) region of the electromagnetic spectrum; andsubsequently detect and analyze a probe signal from a probe light source (e.g., a probe laser) via Fourier-domain optical coherence tomography that simultaneously illuminates the sample;wherein the photothermal response induced by the pump signal is transferred to the probe signal, which is detected as a signal that is analyzed to thereby provide imaging of the sample; andwherein the method performed by the device is label-free and / or substantially free of any added contrast agents.
13. The device of any one of claims 11-12, wherein the device comprises:a pump light source (e.g., a pump laser);a probe light source (e.g., a probe laser);an optical component; anda detector;the pump light source being configured to provide a pump signal;the probe light source being configured to provide a probe signal;the optical component being configured to receive the pump signal and probe signal and focus each onto a sample, and subsequently transmit a measured signal to the detector.
14. The device of any one of claims 11-13, wherein the device comprises:a pump light source (e.g., a pump laser);a probe light source (e.g., a probe laser);a single mode fiber circulator;a dichroic beam combiner;an off-axis parabolic mirror; anda detector;the pump light source being configured to provide a pump signal;the off-axis parabolic mirror being configured to receive the pump signal and focus the pump signal onto the sample;the probe light source being configured to provide a probe signal;the single mode fiber circulator being configured to receive the probe signal from the probe light source and transmit the probe signal to the dichroic beam combiner;the dichroic beam combiner being configured to receive the probe signal from the single mode fiber circulator, and transmit the probe signal to the sample; andthe dichroic beam combiner being further configured to subsequently receive and transmit a measured signal to the detector.
15. The device of any one of claims 11-14, wherein the pump light source comprises a laser.
16. The device of any one of claims 11-15, wherein the probe light source comprises a laser.
17. The device of any one of claims 11-16, the device being as shown in Figure 4.
18. The device of any one of claims 11-17, wherein the device couples photothermal midinfrared spectroscopy to Fourier-domain optical coherence tomography.
19. The device of any one of claims 11-18, wherein the device combines the high-resolution structural imaging of Fourier-domain optical coherence tomography (FD-OCT) with the biochemical contrast of mid-infrared photothermal detection.
20. The device of any one of claims 11-19, wherein the device is miniaturized and compact.
